Why is Anbio Biotechnology seeking share consolidation authority for its Class A Ordinary Shares?

The board cites Nasdaq’s US$1.00 minimum bid price requirement. It wants flexibility to implement one or more reverse splits of Class A shares, at ratios from 2‑for‑1 to up to 10,000‑for‑1, to help support bid price compliance and preserve the Nasdaq listing.

Anbio Biotechnology (NNNN) seeks huge capital increase and 500-vote Class B shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

6-K

Rhea-AI Filing Summary

Anbio Biotechnology is calling a May 15, 2026 Class A meeting and an extraordinary general meeting to overhaul its share capital and governance. Shareholders will vote on reducing par value, then massively increasing authorised capital to up to 800,000,000,000 Class A, 200,000,000,000 Class B, 1,000,000,000,000 Class C and 1,000,000,000,000 preference shares, plus creating non‑voting Class C shares. A key proposal would raise Class B voting power from 50 to 500 votes per share, sharply diluting Class A voting influence. Class B shares would become convertible into Class A, and the board would be authorised to execute one or more reverse share splits of Class A in a 2‑for‑1 to 10,000‑for‑1 range to help support Nasdaq bid‑price compliance. An updated memorandum and articles would embed these changes, tighten meeting requisition thresholds and add an exclusive forum clause. The board unanimously recommends voting in favour of all proposals.

Positive

Expanded authorised capital and new share classes give Anbio flexibility to support future financings, employee plans and strategic transactions by creating very large pools of Class A, Class B, Class C and preference shares.
Share consolidation authority to support Nasdaq compliance allows the board to implement reverse splits of Class A within a 2‑for‑1 to 10,000‑for‑1 range, aiming to help maintain the US$1.00 minimum bid price required for continued listing.

Negative

Sharp concentration of voting power in Class B shares increases voting rights from 50 to 500 votes per Class B share, reducing existing Class A holders’ aggregate voting power from about 0.9% to roughly 0.1% at the stated share counts.
Significant potential dilution from authorised share capital increase raises the authorised pool to 3,000,000,000,000 shares across multiple classes, which could materially dilute existing holders if large future issuances occur.

Insights

Anbio seeks extensive capital flexibility while heavily concentrating voting control.

Anbio Biotechnology is asking holders to approve a multi-part recapitalisation. The plan cuts par value, then boosts authorised capital to US$3,000 divided into 3,000,000,000,000 shares across four classes and introduces non-voting Class C shares, expanding future issuance capacity.

Another core step raises Class B voting power from fifty to five hundred votes per share. Based on shares outstanding as of the April 22, 2026 record date, Class A’s voting power would drop from about 0.9% to roughly 0.1%, further entrenching the controlling holder. Class B would remain economically similar but far more influential in votes.

The board also seeks authority for one or more reverse share splits of Class A within a 2‑for‑1 to 10,000‑for‑1 range, primarily to help maintain Nasdaq’s US$1.00 minimum bid price. Future impact depends on how much of the enlarged authorised pool is actually issued, the chosen consolidation ratio and how investors react to the stronger control structure and new exclusive forum and higher meeting-requisition thresholds.

Key Figures

Class A shares outstanding: 43,891,200 shares Class B shares outstanding: 100,000,000 shares Current voting power split: 0.9% Class A, 99.1% Class B +5 more

8 metrics

Class A shares outstanding 43,891,200 shares As of record date April 22, 2026

Class B shares outstanding 100,000,000 shares As of record date April 22, 2026

Current voting power split 0.9% Class A, 99.1% Class B Based on 1 vote per A and 50 per B before change

Post-change voting power split ≈0.1% Class A, ≈99.9% Class B Assuming 500 votes per Class B share at same counts

New authorised share pool 3,000,000,000,000 shares US$3,000 capital at US$0.000001 par per share

Authorised Class A shares 800,000,000,000 shares Under Authorised Share Capital Increase

Reverse split range 2-for-1 to 10,000-for-1 Share consolidation authorisation for Class A shares

Record date April 22, 2026 Determines holders entitled to vote at Class A Meeting and EGM

Key Terms

Share Capital Reduction, Authorised Share Capital Increase, Increase in Class B Voting Rights, Class B Conversion Rights, +2 more

6 terms

Increase in Class B Voting Rights financial

"to approve an increase in the voting rights attaching to the Class B Ordinary Shares from fifty (50) votes per Class B Ordinary Share to five hundred (500)..."

Class B Conversion Rights financial

"to approve an alteration of the rights attaching to the Class B Ordinary Shares, such that each Class B Ordinary Share shall be convertible into Class A Ordinary Share(s)..."

Restated M&A regulatory

"to adopt the second amended and restated memorandum and articles of association of the Company (the “Restated M&A”)..."

Form 6-K: How Foreign Companies Report to the SEC →

04/27/2026 - 04:30 PM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2026

Commission File Number: 001-42526

Anbio Biotechnology

Friedrich-Ebert-Anlage 35-37, 60327
Frankfurt am Main,
Germany
+49 69870039170

(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

In connection with the extraordinary general meeting of shareholders of Anbio Biotechnology (the “Company”), attached hereto and incorporated by reference herein are Notice of Meetings of Shareholders and Proxy Statement and Form of Proxy Card.

EXHIBIT INDEX

Exhibit No.		Description
99.1		Notice of Meetings of Shareholders and Proxy Statement
99.2		Form of Proxy Card for the Meeting of Shareholders of Class A Ordinary Shares
99.3		Form of Proxy Card for the Meeting of Shareholders of Class A Ordinary Shares and Class B Ordinary Shares
99.4		Amended and Restated Memorandum and Articles of Association

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Anbio Biotechnology

Date: April 27, 2026	By:	/s/ Michael Lau
	Name:	Michael Lau
	Title:	Chief Executive Officer

Exhibit 99.1

Anbio Biotechnology
Friedrich-Ebert-Anlage 35-37, 60327
Frankfurt am Main,
Germany

PROXY STATEMENT AND NOTICE OF

A MEETING OF THE HOLDERS OF CLASS A ORDINARY SHARES

TO BE HELD ON May 15, 2026

AND

PROXY STATEMENT AND NOTICE OF

EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS

TO BE HELD IMMEDIATELY FOLLOWING THE MEETING OF THE HOLDERS OF THE CLASS A ORDINARY SHARES

NOTICE OF A MEETING OF THE HOLDERS OF CLASS A ORDINARY SHARES

April 27, 2026

Dear Shareholder:

Notice is hereby given that a meeting of the holders of class A ordinary shares of a par value of $0.0001 each (the “Class A Ordinary Shares”) (the “Class A Meeting”) of Anbio Biotechnology, a Cayman Islands exempted company (the “Company”), will be held on May 15, 2026 at 3 p.m., Germany Time (May 15, 2026 at 9 a.m., Eastern Time), at Friedrich-Ebert-Anlage 35-37, 60327, Frankfurt am Main, Germany to vote upon a special resolution (the “Class A Proposal”) to approve any variation or abrogation of rights attaching to the Class A Ordinary Shares arising from the matters contemplated by Proposal Two, Proposal Three, Proposal Four, Proposal Five and Proposal Six of the extraordinary general meeting (the “EGM”) to be held immediately following the Class A Meeting (the “EGM”), as set out below:

1. Proposal Two. By an ordinary resolution, subject to and conditional upon the passing of the resolutions set out in Proposal One, Proposal Three, Proposal Four and Proposal Six of the EGM, and with effect immediately following the effectiveness of the Share Capital Reduction, to increase the Company’s authorised share capital from:

(i)

US$0.50 divided into 500,000,000 shares of par value US$0.000000001 each, comprising of 400,000,000 Class A Ordinary Shares of par value US$0.000000001 each and 100,000,000 Class B Ordinary Shares of par value US$0.000000001 each, to

(ii)

US$3,000 divided into 3,000,000,000,000 shares of par value US$0.000000001 each, comprising of 800,000,000,000 Class A Ordinary Shares, 200,000,000,000 Class B Ordinary Shares, 1,000,000,000,000 Class C Ordinary Shares of par value US$0.000000001 each (the “Class C Ordinary Shares”) and 1,000,000,000,000 preference shares of par value US$0.000000001 each (the “Preference Shares”)

by the creation of 799,600,000,000 Class A Ordinary Shares of par value US$0.000000001 each, 199,900,000,000 Class B Ordinary Shares of par value US$0.000000001 each, 1,000,000,000,000 Class C Ordinary Shares of par value US$0.000000001 each, and 1,000,000,000,000 Preference Shares of par value US$0.000000001 each, each having the rights and restrictions set forth in the Restated M&A (as defined below) (the “Authorised Share Capital Increase”).

Proposal Three. By an ordinary resolution, subject to and conditional upon the passing of the resolutions set out in Proposal One, Proposal Two, Proposal Four and Proposal Six of the EGM and all requisite class consents being obtained, and with effect immediately following effectiveness of the Share Capital Reduction (as defined in the EGM resolutions), to approve an increase in the voting rights attaching to the Class B Ordinary Shares (as defined in the EGM resolutions) from fifty (50) votes per Class B Ordinary Share to five hundred (500) votes per Class B Ordinary Share as set forth in the Restated M&A (as defined below) (the “Increase in Class B Voting Rights”);

Proposal Four. By an ordinary resolution, subject to and conditional upon the passing of the resolutions set out in Proposals One to Three and Proposal Six of the EGM and all requisite class consents being obtained, and with effect immediately following effectiveness of the Share Capital Reduction, to approve an alteration of the rights attaching to the Class B Ordinary Shares, such that each Class B Ordinary Share shall be convertible into Class A Ordinary Share(s) in accordance with the terms of the Restated M&A (the “Class B Conversion Rights”);

Proposal Five. By an ordinary resolution, subject to and conditional upon all requisite class consents being obtained:

(i)

to approve one or more share consolidations of the Company’s issued and unissued Class A Ordinary Shares at a ratio of not less than two (2)-for-one (1) and not more than ten-thousand (10,000)-for-one (1) or the maximum consolidation ratio then permitted under applicable Nasdaq rules and requirements aggregately (the “Range”), with the exact ratio to be set as a whole number within the Range and the exact date to be determined by the board of directors of the Company in its sole discretion within three years after the date of passing of the EGM resolutions (each a “Share Consolidation” and collectively, the “Share Consolidations”) provided that the aggregate ratio across all such Share Consolidations shall not exceed ten-thousand (10,000)-for-one (1) or such lower cap as imposed by Nasdaq at the time of implementation and that no fractional share shall arise from the Share Consolidations;

(ii)

to authorise the Company to round up any fractional shares resulting from the Share Consolidations to the nearest whole Class A Ordinary Share; and

(iii)

to authorise the board of directors to, at their sole and absolute discretion, implement one or more Share Consolidations, determine the exact consolidation ratio and the exact effective date of each such Share Consolidation, instruct the registered office provider or transfer agent of the Company to complete the necessary corporate record(s) and filing(s) to reflect the Share Consolidation(s) and do all other such acts and things as the board considers necessary or desirable for the purposes of the transactions contemplated by the Share Consolidation(s); and

Proposal Six. By a special resolution, subject to and conditional upon the passing of the resolutions set out in Proposal One, Proposal Two, Proposal Three and Proposal Four of the EGM and all requisite class consents being obtained, and with effect immediately following effectiveness of the Share Capital Reduction, to adopt the form of amended and restated memorandum and articles of association of the Company in the form attached as Appendix A to the Proxy Statement for the EGM (the “Restated M&A”) in substitution for and to the exclusion of the existing amended and restated memorandum and articles of association of the Company to, among other things: (i) reflect the Share Capital Reduction, the Authorised Share Capital Increase, the Increase in Class B Voting Rights, and the Class B Conversion Rights; (ii) increase threshold for requisitioning a meeting to shareholders holding a majority of the voting rights; (iii) add an exclusive forum and jurisdiction clause; (iv) add prior written notice requirement for directors to vacate their office upon resignation and termination of their terms, and (v) make other consequential and minor updates, and authorise the board of directors to do all other acts and things as the board considers necessary or desirable in connection with the adoption of the Restated M&A, including without limitation, attending to the necessary filing(s) with the Registrar of Companies in the Cayman Islands.

The Board urges shareholders to vote “FOR” the Class A Proposal.

Holders of record of our Class A Ordinary Shares at the close of business on April 22, 2026 (the “Record Date”) are entitled to attend and vote at the Class A Meeting. The interested shareholders (the “Interested Shareholders”), who are the holders of record of both our Class A Ordinary Shares and Class B Ordinary Shares at the close of business on the Record Date, will not attend or vote at the Class A Meeting.

A proxy statement describing the matters to be considered at the Class A Meeting is attached to this Notice.

This notice, proxy statement, and form of proxy card are being distributed and made available on or about on April 27, 2026.

NOTICE OF AN EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS

April 27, 2026

Dear Shareholder:

Notice is hereby given that an extraordinary general meeting of shareholders (the “EGM”) of Anbio Biotechnology, a Cayman Islands exempted company (the “Company”), will be held immediately following the Class A Meeting, at Friedrich-Ebert-Anlage 35-37, 60327, Frankfurt am Main, Germany, for the following proposals:

1. Proposal One. By a special resolution, subject to and conditional upon the passing of the resolutions set out in Proposal Two to Proposal Four and Proposal Six, to approve a reduction in the Company’s authorised share capital from (i) US$50,000 divided into 500,000,000 shares of a par value of US$0.0001 each, comprising of 400,000,000 class A ordinary shares of a par value of US$0.0001 each and 100,000,000 class B ordinary shares of a par value of US$0.0001 each, to (ii) US$0.50 divided into 500,000,000 shares of par value US$0.000000001 each, comprising of 400,000,000 Class A Ordinary Shares of par value US$0.000000001 each (the “Class A Ordinary Shares”) and 100,000,000 Class B Ordinary Shares of par value US$0.000000001 each (the “Class B Ordinary Shares”), by way of reduction of the par value of each authorised share in the capital of the Company (including all issued shares) from US$0.0001 to US$0.000000001 (the “Share Capital Reduction”).

The Board urges shareholders to vote “FOR” Proposal One.

2. Proposal Two. By an ordinary resolution, subject to and conditional upon the passing of the resolutions set out in Proposal One, Proposal Three, Proposal Four and Proposal Six, and with effect immediately following the effectiveness of the Share Capital Reduction, to increase the Company’s authorised share capital from:

(i)

(ii)

The Board urges shareholders to vote “FOR” Proposal Two.

3. Proposal Three. By an ordinary resolution, subject to and conditional upon the passing of the resolutions set out in Proposal One, Proposal Two, Proposal Four and Proposal Six and all requisite class consents being obtained, and with effect immediately following effectiveness of the Share Capital Reduction, to approve an increase in the voting rights attaching to the Class B Ordinary Shares from fifty (50) votes per Class B Ordinary Share to five hundred (500) votes per Class B Ordinary Share as set forth in the Restated M&A (as defined below) (the “Increase in Class B Voting Rights”).

The Board urges shareholders to vote “FOR” Proposal Three.

4. Proposal Four. By an ordinary resolution, subject to and conditional upon the passing of the resolutions set out in Proposals One to Three and Proposal Six and all requisite class consents being obtained, and with effect immediately following effectiveness of the Share Capital Reduction, to approve an alteration of the rights attaching to the Class B Ordinary Shares, such that each Class B Ordinary Share shall be convertible into Class A Ordinary Share(s) in accordance with the terms of the Restated M&A (the “Class B Conversion Rights”).

The Board urges shareholders to vote “FOR” Proposal Four.

5. Proposal Five. By an ordinary resolution, subject to and conditional upon all requisite class consents being obtained: (i) to approve one or more share consolidations of the Company’s issued and unissued Class A Ordinary Shares at a ratio of not less than two (2)-for-one (1) and not more than ten-thousand (10,000)-for-one (1) or the maximum consolidation ratio then permitted under applicable Nasdaq rules and requirements aggregately (the “Range”), with the exact ratio to be set as a whole number within the Range and the exact date to be determined by the board of directors of the Company in its sole discretion within three years after the date of passing of these resolutions (each a “Share Consolidation” and collectively, the “Share Consolidations”) provided that the aggregate ratio across all such Share Consolidations shall not exceed ten-thousand (10,000)-for-one (1) or such lower cap as imposed by Nasdaq at the time of implementation and that no fractional share shall arise from the Share Consolidations; (ii) to authorise the Company to round up any fractional shares resulting from the Share Consolidations to the nearest whole Class A Ordinary Share; and (iii) to authorise the board of directors to, at their sole and absolute discretion, implement one or more Share Consolidations, determine the exact consolidation ratio and the exact effective date of each such Share Consolidation, instruct the registered office provider or transfer agent of the Company to complete the necessary corporate record(s) and filing(s) to reflect the Share Consolidation(s) and do all other such acts and things as the board considers necessary or desirable for the purposes of the transactions contemplated by the Share Consolidation(s) (the “Share Consolidation Authorisation”).

The Board urges shareholders to vote “FOR” Proposal Five.

6. Proposal Six. By a special resolution, subject to and conditional upon the passing of Proposals One, Two, Three and Four and all requisite class consents being obtained, and with effect immediately following effectiveness of the Share Capital Reduction, to adopt the second amended and restated memorandum and articles of association of the Company (the “Restated M&A”) in the form attached as Appendix A to the proxy statement accompanying this notice in substitution for and to the exclusion of the existing amended and restated memorandum and articles of association of the Company to, among other things: (i) reflect the Share Capital Reduction, the Authorised Share Capital Increase, the Increase in Class B Voting Rights, and the Class B Conversion Rights; (ii) increase threshold for requisitioning a meeting to shareholders holding a majority of the voting rights; (iii) add an exclusive forum and jurisdiction clause; (iv) add prior written notice requirement for directors to vacate their office upon resignation and termination of their terms, and (v) make other consequential and minor updates, and authorise the board of directors to do all other acts and things as the board considers necessary or desirable in connection with the adoption of the Restated M&A, including without limitation, attending to the necessary filing(s) with the Registrar of Companies in the Cayman Islands (the “Adoption of the Restated M&A”).

The Board urges shareholders to vote “FOR” Proposal Six.

7. Proposal Seven. By a special resolution, subject to and conditional upon the effectiveness of the first Share Consolidation implemented by the board of directors under Proposal Five, (a) to amend and restate the then effective memorandum and articles of association of the Company (the “Pre-Consolidation M&A”) by their deletion in their entirety and the substitution in their place with an amended and restated memorandum and articles of association (the “Post-Consolidation M&A”), being in the form of the Pre-Consolidation M&A, with amendments to the authorised share capital and par value descriptions to reflect the first Share Consolidation effected pursuant to Proposal Five; and (b) to authorise the Company’s registered office provider or other duly authorised representative to file these resolutions, the Board resolutions in relation to such Share Consolidation and the Post-Consolidation M&A with the Registrar of Companies in the Cayman Islands accordingly and authorise the board of directors to take all further actions and execute all further documents as may be necessary or advisable to carry out the intent of these resolutions (the “Amendment And Restatement of M&A Following First Share Consolidation”).

The Board urges shareholders to vote “FOR” Proposal Seven.

8. Proposal Eight. By an ordinary resolution, to adjourn the EGM to a later date or dates for any purpose, including to solicit additional proxies if there are insufficient votes at the time of the EGM to approve the proposals described above (the “Adjournment Proposal”).

The Board urges shareholders to vote “FOR” Proposal Eight.

Holders of record of our Class A Ordinary Shares and Class B Ordinary Shares at the close of business on April 22, 2026 (the “Record Date”) are entitled to attend and vote at the EGM. The Board urges shareholders to vote “FOR” Proposal One, Proposal Two, Proposal Three, Proposal Four, Proposal Five, Proposal Six, Proposal Seven and Proposal Eight.

A proxy statement describing the matters to be considered at the EGM is attached to this Notice.

This notice, proxy statement, and form of proxy card are being distributed and made available on or about on April 27, 2026.

Your vote is important. Whether or not you plan to attend the EGM, I hope that you will vote as soon as possible. You may vote your shares by either completing, signing and returning the accompanying proxy card or casting your vote over the Internet.

	By Order of the Board of Directors, Sincerely,

	/s/ Michael Lau
	Michael Lau
	Chief Executive Officer

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR A MEETING OF THE HOLDERS OF CLASS A ORDINARY SHARES TO BE HELD ON MAY 15, 2026

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY TO BE HELD IMMEDIATELY FOLLOWING THE MEETING OF THE HOLDERS OF THE CLASS A ORDINARY SHARES.

Anbio Biotechnology
Friedrich-Ebert-Anlage 35-37, 60327,
Frankfurt am Main,
Germany

Proxy Statement

The board of directors (the “Board”) of Anbio Biotechnology, a Cayman Islands exempted company (the “Company,” or “we”), is furnishing this Proxy Statement and the accompanying proxy card to you to solicit your proxy for a meeting of the holders of class A ordinary shares of a par value of $0.0001 each of the Company (the “Class A Ordinary Shares”) (the “Class A Meeting”) and an extraordinary general meeting of shareholders of the Company (the “EGM”). The Class A Meeting will be held on May 15, 2026 at 3 p.m., Germany Time (May 15, 2026 at 9 a.m., Eastern Time), at Friedrich-Ebert-Anlage 35-37, 60327, Frankfurt am Main, Germany. The Meeting will be held immediately following the Class A Meeting, at Friedrich-Ebert-Anlage 35-37, 60327, Frankfurt am Main, Germany. The Class A Meeting and the EGM are collectively referred to as the “Meetings” and each a “Meeting”.

QUESTIONS AND ANSWERS ABOUT THE MEETINGS

What is this proxy statement?

You have received this proxy statement because our Board is soliciting your proxy to vote your shares at the Meetings. This proxy statement includes information that we are required to provide to you under the rules of the Securities and Exchange Commission (“SEC”) and that is designed to assist you in voting your shares.

What is the purpose of the Meetings?

At the Class A Meeting, our shareholders of Class A Ordinary Shares except the Interested Shareholders (defined below), will vote upon a special resolution to approve any variation or abrogation of rights attaching to the Class A Ordinary Shares arising from the following matters: 1) the Authorised Share Capital Increase, 2) the Increase in Class B Voting Rights, 3) the Class B Conversion Rights, 4) the Share Consolidation Authorisation, and 5) the Adoption of the Restated M&A (the “Class A Proposal”).

At the EGM, our shareholders of Class A Ordinary Shares and Class B Ordinary Shares will vote upon the following matters: 1) the Share Capital Reduction, 2) the Authorised Share Capital Increase, 3) the approval of the Increase in Class B Voting Rights, 4) the approval of the Class B Conversion Rights, 5) the approval of the Share Consolidation Authorisation, 6) the Adoption of the Restated M&A, 7) the Amendment And Restatement of M&A Following First Share Consolidation, and 8) the approval of the Adjournment of the EGM.

What are the Board’s recommendations?

At the Class A Meeting, our Board recommends that you vote “FOR” the Class A Proposal.

At the EGM, our Board recommends that you vote:

●

“FOR” the Share Capital Reduction;

●

“FOR” the Authorised Share Capital Increase;

●

“FOR” the Increase in Class B Voting Rights;

●

“FOR” the Class B Conversion Rights;

●

“FOR” the Share Consolidation Authorisation;

●

“FOR” the Adoption of the Restated M&A;

●

“FOR” the Amendment and Restatement of M&A Following First Share Consolidation; and

●

“FOR” the Adjournment of the EGM.

Who is entitled to attend and vote at the Meetings?

Only shareholders of Class A Ordinary Shares of record at the close of business on April 22, 2026, which we refer to as the Record Date, are entitled to receive notice of, and to attend and vote at, the Class A Meeting. The interested shareholders (the “Interested Shareholders”), who are the holders of record of both our Class A Ordinary Shares and Class B Ordinary Shares at the close of business on the Record Date, will not attend or vote at the Class A Meeting.

Only shareholders of Class A Ordinary Shares and Class B Ordinary Shares of record at the close of business on the Record Date, are entitled to receive notice of, and to attend and vote at, the EGM.

As of the Record Date, there were 43,891,200 Class A Ordinary Shares (or 39,691,200 Class A Ordinary Shares, excluding the Interested Shareholders’ Class A Ordinary Shares) and 100,000,000 Class B Ordinary Shares outstanding. Holders of Class A Ordinary Shares as of the Record Date are entitled to one (1) vote for each Class A Ordinary Share held for each of the proposals and holders of Class B Ordinary Shares as of the Record Date are entitled to fifty (50) votes for each Class B Ordinary Share held for each of the proposals.

A list of shareholders entitled to vote at each Meeting will be available at such Meeting.

What is the difference between holding shares as a shareholder of record and as a beneficial owner?

Shareholder of Record. If your shares are registered directly in your name with our transfer agent, Transhare Corporation, you are considered, with respect to those shares, the “shareholder of record.” This proxy statement has been sent directly to you by us.

Beneficial Owner. If your shares are held in a stock brokerage account or by a bank or other nominee, you are considered the “beneficial owner” of shares held in street name. This proxy statement has been forwarded to you by your broker, bank or nominee who is considered, with respect to those shares, the shareholder of record. As the beneficial owner, you have the right to direct your broker, bank or nominee how to vote your shares by using the voting instructions included with your proxy materials.

How do I vote my shares?

Shareholders can vote in person at the Meetings or by proxy. There are two ways to vote by proxy:

To vote by Internet

You can vote over the Internet by going to www.transhare.com, clicking on Vote Your Proxy, logging in using the control number and following the instructions to vote your shares;

To vote by Mail

You can vote by mail by signing, dating and mailing the enclosed proxy card;

To vote by Email

Please email your signed proxy card to Proxy@Transhare.com; or

If you vote via the internet, your electronic vote authorizes the named proxies in the same manner as if you signed, dated, and returned your proxy card. If you vote via the internet, do not return your proxy card.

If your shares are held in the name of a bank, broker or other holder of record, you will receive instructions from the holder of record. You must follow the instructions of the holder of record in order for your shares to be voted. Internet voting also will be offered to shareholders owning shares through certain banks and brokers. If your shares are not registered in your own name and you plan to vote your shares in person at the Meeting, you should contact your broker or agent to obtain a legal proxy or broker’s proxy card and bring it to the Meeting in order to vote.

If you vote by proxy, the individuals named on the proxy card (your “proxies”) will vote your shares in the manner you indicate. You may specify how your shares should be voted for each of the proposals. If you grant a proxy without indicating your voting instructions, your shares will be voted as follows:

At the Class A Meeting, “FOR” the Class A Proposal.

At the EGM,

●

“FOR” the Share Capital Reduction;

●

“FOR” the Authorised Share Capital Increase;

●

“FOR” the Increase in Class B Voting Rights;

●

“FOR” the Class B Conversion Rights;

●

“FOR” the Share Consolidation Authorisation;

●

“FOR” the Adoption of the Restated M&A;

●

“FOR” the Amendment and Restatement of M&A following first Share Consolidation; and

●

“FOR” the Adjournment of the EGM.

What constitutes a quorum?

According to the Company’s currently effective memorandum and articles of association, a meeting of shareholders is duly constituted if, at the commencement of the meeting, there are present in person, through their authorised representative or by proxy holding in aggregate at least one-third of all votes attaching to all shares in issue and entitled to vote at such general meeting.

The Class A Meeting will be duly constituted if, at the commencement of the Class A Meeting, there are present in person, through their authorised representative or by proxy holding in aggregate at least one-third of all votes attaching to all Class A Ordinary Shares in issue and entitled to vote at the Class A Meeting.

The EGM will be duly constituted if, at the commencement of the EGM, there are present in person, through their authorised representative or by proxy holding in aggregate at least one-third of all votes attaching to all Class A Ordinary Shares and Class B Ordinary Shares in issue and entitled to vote at the EGM.

What is a broker “non-vote” and what is its effect on voting?

If you are a beneficial owner of shares held in street name and do not provide the organization that holds your shares with specific voting instructions, under the rules of various national and regional securities exchanges, the organization that holds your shares may generally vote on routine matters but cannot vote on non-routine matters. If the organization that holds your shares does not receive instructions from you on how to vote your shares on a non-routine matter, the organization that holds your shares does not have the authority to vote on the matter with respect to those shares. This is generally referred to as a “broker non-vote.”

How will shares be voted at the Meetings?

In accordance with the Company’s currently effective memorandum and articles of association, all resolutions put to the vote of the Meetings shall be decided by way of a poll.

What is required to approve each item?

At the Class A Meeting, the affirmative vote of a majority of not less than two-thirds of the votes cast by such shareholders as, being entitled to do so, vote in person or by proxy at the Class A Meeting is required to pass the Class A Proposal.

At the EGM, the following approvals are required for each Proposal:

●

For Proposal One, the affirmative vote of a majority of not less than two-thirds of the votes cast by such shareholders as, being entitled to do so, vote in person or by proxy at the EGM is required.

●

For Proposal Two, the affirmative vote of a simple majority of the votes cast by such shareholders as, being entitled to do so, vote in person or by proxy at the EGM, is required.

●

For Proposal Three, the affirmative vote of a simple majority of the votes cast by such shareholders as, being entitled to do so, vote in person or by proxy at the EGM, is required.

●

For Proposal Four, the affirmative vote of a simple majority of the votes cast by such shareholders as, being entitled to do so, vote in person or by proxy at the EGM, is required.

●

For Proposal Five, the affirmative vote of a simple majority of the votes cast by such shareholders as, being entitled to do so, vote in person or by proxy at the EGM, is required.

●

For Proposal Six, the affirmative vote of a majority of not less than two-thirds of the votes cast by such shareholders as, being entitled to do so, vote in person or by proxy at the EGM, is required.

●

For Proposal Seven, the affirmative vote of a majority of not less than two-thirds of the votes cast by such shareholders as, being entitled to do so, vote in person or by proxy at the EGM, is required.

●

For Proposal Eight, the affirmative vote of a simple majority of the votes cast by such shareholders as, being entitled to do so, vote in person or by proxy at the EGM, is required.

For the purpose of determining whether the shareholders have approved Proposal One, Proposal Two and Proposal Three at the Class A Meeting, and Proposal One, Proposal Two, Proposal Three, Proposal Four, Proposal Five, Proposal Six and Proposal Seven at the EGM, abstentions and broker non-votes, if any, will not be counted as votes cast and will not affect the outcome of these Proposals. Abstentions will be counted for purposes of determining whether there is a quorum present.

For the purpose of determining whether the shareholders have approved Proposal Eight at the EGM, abstentions, if any, will not be counted as votes cast and will not affect the outcome of these Proposals, although they will be counted for purposes of determining whether there is a quorum present. If shareholders hold their shares through a broker, bank or other nominee and do not instruct them how to vote, the broker may have authority to vote the shares for Proposal Eight, which is considered a routine matter.

How will Class A Ordinary Shares and Class B Ordinary Shares represented by properly executed proxies be voted?

At each Meeting, all Class A Ordinary Shares and Class B Ordinary Shares, as applicable, represented by proper proxies will, unless such proxies have previously been revoked, be voted in accordance with the instructions indicated in such proxies. If you do not provide voting instructions, your shares will be voted in accordance with the Board’s recommendations as set forth herein. Holders of Class A Ordinary Shares as of the Record Date are entitled to one (1) vote for each Class A Ordinary Share held for each of the proposals at the Class A Meeting and the EGM, and holders of Class B Ordinary Shares as of the Record Date are entitled to fifty (50) votes for each Class B Ordinary Share held for each of the proposals at the EGM. See “Who is entitled to attend and vote at the Meetings?” for more information.

Can I change my vote or revoke my proxy?

Any shareholder executing a proxy has the power to revoke such proxy at any time prior to its exercise. You may revoke your proxy prior to exercise by:

●

filing with us a written notice of revocation of your proxy,

●

submitting a properly signed proxy card bearing a later date,

●

voting over the Internet, or

●

voting in person at the Meetings.

What does it mean if I receive more than one set of proxy materials?

If your shares are registered under different names or are in more than one account, you may receive more than one set of proxy materials. To ensure that all your shares are voted, please vote through the Internet using each personal identification number you are provided, or complete, sign and date the multiple proxy cards relating to your multiple accounts. We encourage you whenever possible to have all accounts registered in the same name and address. You can accomplish this by contacting our transfer agent, Transhare Corporation at (303) 662-1112.

Who paid for this proxy solicitation?

The cost of preparing, printing, assembling and mailing this proxy statement and other material furnished to shareholders in connection with the solicitation of proxies is borne by us.

How do I learn the results of the voting at the Meetings?

Preliminary results will be announced at the Meetings. Final results will be published in a Report on Form 6-K filed with the SEC.

How are proxies solicited?

In addition to the mail solicitation of proxies, our officers, directors, employees and agents may solicit proxies by written communication, telephone or personal call. These persons will receive no special compensation for any solicitation activities. We will reimburse banks, brokers and other persons holding Class A Ordinary Shares and/or Class B Ordinary Shares for their expenses in forwarding proxy solicitation materials to beneficial owners of our Class A Ordinary Shares and/or Class B Ordinary Shares.

What is “householding?”

“Householding” means that we deliver a single set of proxy materials when requested to households with multiple shareholders, provided certain conditions are met. Householding reduces our printing and mailing costs.

If you or another shareholder of record sharing your address would like to receive an additional copy of the proxy materials, we will promptly deliver it to you upon your request by sending a written request by mail to:

Anbio Biotechnology

Friedrich-Ebert-Anlage 35-37, 60327,

Frankfurt am Main,

Germany

If you would like to opt out of householding in future mailings, or if you are currently receiving multiple mailings at one address and would like to request householded mailings, you may do so by contacting our Corporate Secretary as indicated above.

Can I receive future shareholder communications electronically through the Internet?

Yes. You may elect to receive future notices of future meetings, proxy materials and annual reports electronically through the Internet. To consent to electronic delivery, vote your shares using the Internet. At the end of the Internet voting procedure, the on-screen Internet voting instructions will tell you how to request future shareholder communications be sent to you electronically.

Once you consent to electronic delivery, you must vote your shares using the Internet and your consent will remain in effect until withdrawn. You may withdraw this consent at any time during the voting process and resume receiving shareholder communications in print form.

Whom may I contact for further assistance?

If you have any questions about giving your proxy or require any assistance, please contact us by mail, to:

Anbio Biotechnology

Friedrich-Ebert-Anlage 35-37, 60327,

Frankfurt am Main,

Germany

The proposal for the Class A Meeting is as follows:

We are proposing a special resolution of the holders of the Class A Ordinary Shares (the “Class A Proposal”) to approve any variation or abrogation of rights attaching to the Class A Ordinary Shares arising from the matters contemplated by Proposal Two, Proposal Three, Proposal Four, Proposal Five and Proposal Six of the EGM.

Vote Required

The Class A Proposal requires the affirmative (“FOR”) vote of at least two-thirds of votes cast by shareholders present or represented by proxy and entitled to vote at the Class A Meeting. Unless otherwise instructed on the proxy or unless authority to vote is withheld, shares represented by executed proxies will be voted “FOR” this proposal. Abstentions or broker non-votes, if any, will not be counted as votes cast, although abstentions and broker non-votes will be counted for purposes of determining whether there is a quorum present.

Recommendation of the Board of Directors

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE SHAREHOLDERS VOTE “FOR” THIS PROPOSAL.

Descriptions of Proposal Two, Proposal Three, Proposal Four, Proposal Five and Proposal Six of the EGM are set out below. Such proposals will be voted on individually at the EGM, to be held immediately following the conclusion of the Class A Meeting.

PROPOSAL TWO

TO APPROVE THE AUTHORISED SHARE CAPITAL INCREASE AND CREATION OF NEW SHARE CLASSES

General

We are proposing to approve, with effect immediately following effectiveness of the Share Capital Reduction, an increase the Company’s authorised share capital from:

(i)

(ii)

Effects of the Authorized Share Capital Increase and Creation of New Share Classes

The classes of shares in the capital of the Company will be changed from Class A Ordinary Shares and Class B Ordinary Shares to Class A Ordinary Shares, Class B Ordinary Shares, Class C Ordinary Share and Preference Shares. Subject to Proposals Four and Six being duly passed at the EGM, each outstanding Class B Ordinary Share will be convertible at any time after issuance at the option of the holder into one (1) Class A Ordinary Share. The Class A Ordinary Shares and Class C Ordinary Shares will not be convertible into shares of any other class. Each Class C Ordinary Shares will have the same rights as the existing Class A Ordinary Shares except that the Class C Ordinary Shares will not have voting rights.

PROPOSAL THREE

TO APPROVE THE INCREASE IN CLASS B VOTING RIGHTS

Background

We are proposing to approve an increase of the voting rights attached to the Class B Ordinary Shares from fifty (50) votes per share to five hundred (500) votes per share as set forth in the Restated M&A (the “Increase in Class B Voting Rights”).

Rationale of the Increase in Class B Voting Rights

The Company has two classes of ordinary shares. Class A Ordinary Shares, each carrying one (1) vote per share on all matters subject to vote at general meetings of the Company, and Class B Ordinary Shares, each carrying fifty (50) votes per share on all matters subject to vote at general meetings of the Company.

Following the Company’s recent financing transactions and in anticipation of potential future financing transactions, employee incentive plans and other equity issuances that may be undertaken from time to time, it is desirable to ensure that the controlling shareholder of the Company will be able to execute its long-term business plans and maintain consistency in strategic direction.

The Increase in Class B Voting Rights will not alter the total number of authorised shares of any class or the economic rights, dividend rights or conversion rights of any shares, but will increase the voting power attached to each Class B Ordinary Share from fifty (50) votes per share to five hundred (500) votes per share.

Effects of the Increase in Class B Voting Rights

Although the Board believes that the Increase in Class B Voting Rights is in the best and commercial interests of the Company and shareholders, the voting rights of Class A Ordinary Shares will be diluted if this Proposal is approved. On the Record Date, there were 43,891,200 Class A Ordinary Shares issued and outstanding, representing 43,891,200 votes or approximately 0.9% of the total voting power, and 100,000,000 Class B Ordinary Shares issued and outstanding, representing 5,000,000,000 votes or approximately 99.1% of the total voting power. Assuming this Proposal is approved, the Class A Ordinary Shares issued and outstanding as of the Record Date will collectively account for approximately 0.1% of the total voting power, and Class B Ordinary Shares issued and outstanding as of the Record Date will collectively account for approximately 99.9% of the total voting power.

PROPOSAL FOUR

TO APPROVE THE CLASS B CONVERSION RIGHTS

Background

We are proposing to approve an alteration of the rights attaching to the Class B Ordinary Shares, such that each Class B Ordinary Share shall be convertible into Class A Ordinary Share(s) in accordance with the terms of the Restated M&A (the “Class B Conversion Rights”).

The Proposed Amendment to Article 27, Article 28 and Article 29 of the Articles of Association

If Proposal Four (and each other proposal upon which it is conditioned) is approved, the Company’s currently effective amended and restated memorandum and articles of association will be substituted in its entirety with a revised form of amended and restated memorandum and articles of association (the “Restated M&A”). The effect of the adoption of the Restated M&A in respect of conversion rights is that Article 27 of the existing amended and restated articles of association of the Company will be replaced with Article 27 as set out below, and new Articles 28 and 29, each set out below, will be incorporated in the Restated M&A:

27.

Except as expressly set forth in Article 28 below, Class A Ordinary Shares, Class B Ordinary Shares and Class C Ordinary Shares shall not be convertible into any other Class of Shares under any circumstances.

28.

Each Class B Ordinary Share is convertible into one (1) Class A Ordinary Share at any time at the option of the holder thereof, subject to and in accordance with this Article and Article 29 below. The right to convert shall be exercisable by the holder of the Class B Ordinary Share delivering a written notice to the Company that such holder elects to convert a specified number of Class B Ordinary Shares into Class A Ordinary Shares.

29.

Any conversion of Class B Ordinary Shares into Class A Ordinary Shares pursuant to these Articles shall be effected by means of compulsory redemption without notice of each relevant Class B Ordinary Share and, on behalf of the holder thereof, automatic application of such redemption proceeds in paying for such new Class A Ordinary Shares into which the Class B Ordinary Shares have been converted at a price per Class B Ordinary Share necessary to give effect to a conversion calculated on the basis that the Class A Ordinary Shares to be issued as part of the conversion will be issued at par.

Rationale of the Class B Conversion Rights

The Company currently has two classes of ordinary shares. Class A Ordinary Shares, each carrying one (1) vote per share on all matters subject to vote at general meetings of the Company, and Class B Ordinary Shares, each carrying fifty (50) votes per share on all matters subject to vote at general meetings of the Company.

The proposed change will allow the Class B Ordinary Shares to be converted into Class A Ordinary Shares in accordance with the Restated M&A. By aligning the rights and interests of both Class A and Class B shareholders, this change can enhance flexibility and long-term alignment among the shareholders.

PROPOSAL FIVE

TO APPROVE THE SHARE CONSOLIDATION AUTHORISATION

Background

We are proposing, (a) to approve one or more share consolidations of the Company’s issued and unissued Class A Ordinary Shares at a ratio of not less than two (2)-for-one (1) and not more than ten-thousand (10,000)-for-one (1) or the maximum consolidation ratio then permitted under applicable Nasdaq rules and requirements aggregately (the “Range”), with the exact ratio to be set as a whole number within the Range and the exact date to be determined by the board of directors of the Company in its sole discretion within three years after the date of passing of these resolutions (each a “Share Consolidation” and collectively, the “Share Consolidations”) provided that the aggregate ratio across all such Share Consolidations shall not exceed ten-thousand (10,000)-for-one (1) or such lower cap as imposed by Nasdaq at the time of implementation and that no fractional share shall arise from the Share Consolidations; (b) to authorise the Company to round up any fractional shares resulting from the Share Consolidations to the nearest whole Class A Ordinary Share, and (c) to authorise the board of directors to, at their sole and absolute discretion, implement one or more Share Consolidations, determine the exact consolidation ratio and the exact effective date of each such Share Consolidation, instruct the registered office provider or transfer agent of the Company to complete the necessary corporate record(s) and filing(s) to reflect the Share Consolidation(s) and do all other such acts and things as the board considers necessary or desirable for the purposes of the transactions contemplated by the Share Consolidation(s).

Purpose of Share Consolidations

The Company’s Class A Ordinary Shares are listed on The Nasdaq Global Market (“Nasdaq”) under the trading symbol of “NNNN.” In order for the Class A Ordinary Shares to continue to be listed on Nasdaq, the Company must satisfy various listing standards established by Nasdaq. Specifically, Nasdaq Listing Rule 5550(a)(2) requires that listed shares maintain a minimum bid price of US$1.00 per share (the “Bid Price Rule”). Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the Minimum Bid Price Requirement exists if the deficiency continues for a period of 30 consecutive trading days. Upon such failure, the Company will receive a written notice from the Nasdaq Listing Qualifications Department and will be provided an initial compliance period of 180 calendar days to regain compliance with the Bid Price Rule. If the Company does not regain compliance within the allotted compliance period, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Company’s Class A Ordinary Shares will be subject to delisting. The Company would then be entitled to appeal Nasdaq’s determination to a Nasdaq Listing Qualifications Panel and request a hearing.

The Board believes that the delisting of the Class A Ordinary Shares from the Nasdaq Global Market (“Nasdaq”) would likely result in decreased liquidity. Such decreased liquidity would result in the increase in the volatility of the trading price of the Class A Ordinary Shares, a loss of current or future coverage by certain analysts and a diminution of institutional investor interest. In addition, the Board believes that such delisting could also cause a loss of confidence of corporate partners, customers and employees, which could harm the Company’s business and future prospects.

To enhance the Company’s ability to retain compliance with the bid price requirement and remain listed on Nasdaq, the Board believes that it is in the best interest of the Company and the shareholders to authorize the Board to effectuate one or more share consolidations to increase the market price of the Class A Ordinary Shares to meet the bid price requirement if needed. As a result, the Board is soliciting shareholders’ approval of the authorization to the Board to effect one or more share consolidations (each a “Share Consolidation” and collectively, the “Share Consolidations”) within the Range to be determined by the Board in its sole discretion within three years after the shareholders’ approval (and if the Board does not determine a ratio and approve any Share Consolidation within such three year period, no Share Consolidation will proceed), and to provide authorization to the Board to settle as it considers expedient any difficulty which arises in relation to any consolidation of Class A Ordinary Shares of the Company to round up any fractions of Class A Ordinary Shares issued to or registered in the name of such shareholders of the Company following or as a result of any Share Consolidation.

In evaluating whether or not to conduct a Share Consolidation under the Share Consolidation Authorisation, the Board will also take into account various negative factors associated with such corporate action. These factors include: the negative perception of share consolidation held by some investors, analysts and other stock market participants; the fact that the share prices of some companies and the Company that have effected of share consolidation have subsequently declined back to pre-consolidation levels; the adverse effect on liquidity that might be caused by a reduced number of shares outstanding; and the costs associated with implementing a share consolidation.

The Board considered these factors, and the potential harm of being delisted from Nasdaq. The Board determined that continued listing on Nasdaq is in the best interest of the Company and its shareholders, and that the Share Consolidation Authorisation (and any Share Consolidation thereunder) is probably necessary to maintain the listing of the Class A Ordinary Shares on Nasdaq.

In addition, there can be no assurance that, after the Share Consolidation Authorisation, the Company will be able to maintain the listing of the Class A Ordinary Shares on Nasdaq. Nasdaq maintains several other continued listing requirements currently applicable to the listing of the Class A Ordinary Shares. Shareholders should recognize that if any Share Consolidation is effected, they will own a smaller number of Class A Ordinary Shares than they currently own. While the Company expects that each Share Consolidation will result in an increase in the market price of the Class A Ordinary Shares, it may not increase the market price of the Class A Ordinary Shares in proportion to the reduction in the number of Class A Ordinary Shares outstanding or result in a permanent increase in the market price (which depends on many factors, including but not limited to our performance, prospects and other factors that may be unrelated to the number of shares outstanding).

If a Share Consolidation is effected and the market price of the Class A Ordinary Shares declines, the percentage decline as an absolute number and as a percentage of the Company’s overall market capitalization may be greater than would occur in the absence of that Share Consolidation. Furthermore, the liquidity of the Class A Ordinary Shares could be adversely affected by the reduced number of shares that would be outstanding after a Share Consolidation. Accordingly, any Share Consolidation may not achieve the desired results that have been outlined above.

Fractional Shares

No fractional shares shall be issued upon a Share Consolidation being effected under the Share Consolidation Authorisation. Upon approval of this Resolution, the directors will be authorized to round up any fractions of Class A Ordinary Shares for issuing to such shareholders of the Company who are entitled to fractional shares following or as a result of a Share Consolidation.

Effects of the Share Consolidation

Authorized Shares and Unissued Shares

At the time each Share Consolidation is effective, our authorized Class A Ordinary Shares will be consolidated at the ratio within the Range, accompanied by a corresponding increase in the par value of the Class A Ordinary Shares, with the exact ratio to be set at a whole number within this range, to be determined by the Board.

Issued and Outstanding Shares

Each Share Consolidation conducted under the Share Consolidation Authorisation will also reduce the number of issued and outstanding Class A Ordinary Shares at the ratio within the Range, accompanied by a corresponding increase in the par value of the Class A Ordinary Shares, with the exact ratio to be set at a whole number within this range, to be determined by the Board.

Each shareholder’s proportionate ownership of the issued and outstanding Class A Ordinary Shares immediately following the effectiveness of a Share Consolidation will remain the same, with the exception of adjustments related to the treatment of fractional shares (see above).

Proportionate adjustments will be made based on the ratio of the Share Consolidation to the per share exercise price and the number of shares issuable upon the exercise or conversion of all outstanding options, warrants, convertible or exchangeable securities entitling the holders to purchase, exchange for, or convert into, our Class A Ordinary Shares. This will result in approximately the same aggregate price being required to be paid under such options, warrants, convertible or exchangeable securities upon exercise, and approximately the same value of Class A Ordinary Shares being delivered upon such exercise, exchange or conversion, immediately following any Share Consolidation as was the case immediately preceding the Share Consolidation.

Procedure for Implementing the Share Consolidation

As soon as practicable after the effective date of any Share Consolidation conducted under the Share Consolidation Authorisation, the Company’s shareholders will be notified that the Share Consolidation has been effected through filing with SEC by the Company. The Company expects that its transfer agent, Transhare Corporation, will act as exchange agent for purposes of implementing the exchange of share certificates. If needed, holders of pre-consolidation shares will be asked to surrender to the exchange agent certificates representing pre-consolidation Class A Ordinary Shares in exchange for certificates representing post-consolidation Class A Ordinary Shares or, in the case of holders of non-certificated shares, such proof of ownership as required by the exchange agent, in accordance with the procedures to be set forth in a letter of transmittal that the Company will send to its registered shareholders. No new share certificates will be issued to a shareholder until such shareholder has surrendered such shareholder’s outstanding share certificate(s) together with the properly completed and executed letter of transmittal to the exchange agent.

SHAREHOLDERS SHOULD NOT DESTROY ANY SHARE CERTIFICATE(S) AND SHOULD NOT SUBMIT ANY CERTIFICATE(S) UNTIL REQUESTED TO DO SO.

Banks, brokers or other nominees will be instructed to effect each Share Consolidation for their beneficial holders holding shares in “street name.” However, these banks, brokers or other nominees may have different procedures from those that apply to registered shareholders for processing each Share Consolidation. If a shareholder holds shares with a bank, broker or other nominee and has any questions in this regard, shareholders are encouraged to contact their bank, broker or other nominee.

PROPOSAL SIX

TO APPROVE AND ADOPT THE RESTATED M&A

General

We are proposing to approve, by a special resolution, subject to and conditional upon the passing of Proposals One, Two, Three and Four at the EGM and all requisite class consents being obtained, and with effect immediately following effectiveness of the Share Capital Reduction, the adoption of the second amended and restated memorandum and articles of association of the Company in the form attached as Appendix A to the proxy statement of the EGM in substitution for and to the exclusion of the existing amended and restated memorandum and articles of association of the Company to, among other things: (i) reflect the Share Capital Reduction, the Authorised Share Capital Increase, the Increase in Class B Voting Rights, and the Class B Conversion Rights; (ii) increase threshold for requisitioning a meeting to shareholders holding a majority of the voting rights; (iii) add an exclusive forum and jurisdiction clause; (iv) add prior written notice requirement for directors to vacate their office upon resignation and termination of their terms, and (v) make other consequential and minor updates, as more particularly described in the Restated M&A, and authorize the board of directors to do all other acts and things as the board considers necessary or desirable in connection with the adoption of the Restated M&A, including without limitation, attending to the necessary filing with the Registrar of Companies in the Cayman Islands.

The proposals for the EGM are as follows:

PROPOSAL ONE

TO APPROVE THE SHARE CAPITAL REDUCTION

Background

We are proposing to approve a reduction in the Company’s authorised share capital from (i) US$50,000 divided into 500,000,000 shares of a par value of US$0.0001 each, comprising of 400,000,000 class A ordinary shares of a par value of US$0.0001 each and 100,000,000 class B ordinary shares of a par value of US$0.0001 each, to (ii) US$0.50 divided into 500,000,000 shares of par value US$0.000000001 each, comprising of 400,000,000 Class A Ordinary Shares of par value US$0.000000001 each ( the “Class A Ordinary Shares”) and 100,000,000 Class B Ordinary Shares of par value US$0.000000001 each (the “Class B Ordinary Shares”), by way of reduction of the par value of each authorised share in the capital of the Company (including all issued shares) from US$0.0001 to US$0.000000001 (the “Share Capital Reduction”).

Purpose of the Share Capital Reduction

The primary reason for this adjustment is to comply with Cayman Islands law, which prohibits the issuance of shares at a price below their par value (other than in certain limited circumstances provided for in the Companies Act (as amended) of the Cayman Islands).

In addition, the Company is proposing to effect the Share Consolidation Authorisation in Proposal Five, which is intended to facilitate compliance with Nasdaq’s minimum bid price requirement for continued listing. Any Share Consolidation conducted pursuant to the Share Consolidation Authorisation is expected to increase the trading price of the Company’s Class A Ordinary Shares, thereby enhancing compliance with Nasdaq’s listing standards.

It should be noted that each Share Consolidation under the Share Consolidation Authorisation will proportionally increase the par value per share in accordance with the selected split ratio. Consequently, this may impose additional constraints on the Company’s ability to raise capital in the future, as any subsequent share issuances will need to be priced at or above the increased par value, subject to applicable legal and regulatory requirements.

By reducing the par value to US$0.000000001 per share, we aim to enhance our flexibility in capital raising activities, ensuring that we can issue shares at a price that is both legally compliant and economically viable. This change will better align our share issuance practices with the dynamic nature of the financial markets, ultimately supporting the Company’s growth and stability.

Vote Required

This Proposal requires the affirmative (“FOR”) vote of at least two-thirds of votes cast by shareholders present or represented by proxy and entitled to vote at the EGM. Unless otherwise instructed on the proxy or unless authority to vote is withheld, shares represented by executed proxies will be voted “FOR” this proposal. Abstentions or broker non-votes, if any, will not be counted as votes cast, although abstentions and broker non-votes will be counted for purposes of determining whether there is a quorum present.

Recommendation of the Board of Directors

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE SHAREHOLDERS VOTE “FOR” THIS PROPOSAL.

PROPOSAL TWO

TO APPROVE THE AUTHORISED SHARE CAPITAL INCREASE AND CREATION OF NEW SHARE CLASSES

Background

We are proposing to approve, with effect immediately following effectiveness of the Share Capital Reduction, an increase the Company’s authorised share capital from:

(i)

(ii)

Effects of the Authorized Share Capital Increase and Creation of New Shares Classes

Vote Required

This Proposal requires the affirmative (“FOR”) vote of a simple majority of votes cast by shareholders present or represented by proxy and entitled to vote at the EGM. Unless otherwise instructed on the proxy or unless authority to vote is withheld, shares represented by executed proxies will be voted “FOR” this proposal. Abstentions or broker non-votes, if any, will not be counted as votes cast, although abstentions and broker non-votes will be counted for purposes of determining whether there is a quorum present.

Recommendation of the Board of Directors

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE SHAREHOLDERS VOTE “FOR” THIS RESOLUTION.

PROPOSAL THREE

TO APPROVE THE INCREASE IN CLASS B VOTING RIGHTS

Background

Rationale of the Increase in Class B Voting Rights

Effects of the Increase in Class B Voting Rights

Vote Required

Recommendation of the Board of Directors

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE SHAREHOLDERS VOTE “FOR” THIS PROPOSAL.

PROPOSAL FOUR

TO APPROVE THE CLASS B CONVERSION RIGHTS

Background

The Proposed Amendment to Article 27, Article 28 and Article 29 of the Articles of Association

27.

28.

Each Class B Ordinary Share is convertible into one (1) Class A Ordinary Share at any time at the option of the holder thereof, subject to and in accordance with this Article and Article 28 below. The right to convert shall be exercisable by the holder of the Class B Ordinary Share delivering a written notice to the Company that such holder elects to convert a specified number of Class B Ordinary Shares into Class A Ordinary Shares.

29.

Rationale of the Class B Conversion Rights

Vote Required

Recommendation of the Board of Directors

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE SHAREHOLDERS VOTE “FOR” THIS RESOLUTION.

PROPOSAL FIVE

TO APPROVE THE SHARE CONSOLIDATION AUTHORISATION

Background

Purpose of Share Consolidations

To enhance the Company’s ability to retain the compliance with the bid price requirement and remain listed on Nasdaq, the Board believes that it is in the best interest of the Company and the shareholders to authorize the Board to effectuate one or more share consolidations to increase the market price of the Class A Ordinary Shares to meet the bid price requirement if needed. As a result, the Board is soliciting shareholders’ approval of the authorization to the Board to effect one or more share consolidations (each a “Share Consolidation” and collectively, the “Share Consolidations”) within the Range to be determined by the Board in its sole discretion within three years after the shareholders’ approval (and if the Board does not determine a ratio and approve any Share Consolidation within such three year period, no Share Consolidation will proceed), and to provide authorization to the Board to settle as it considers expedient any difficulty which arises in relation to any consolidation of Class A Ordinary Shares of the Company to round up any fractions of Class A Ordinary Shares issued to or registered in the name of such shareholders of the Company following or as a result of any Share Consolidation.

Fractional Shares

Effects of the Share Consolidation

Authorized Shares and Unissued Shares

Issued and Outstanding Shares

Procedure for Implementing the Share Consolidation

SHAREHOLDERS SHOULD NOT DESTROY ANY SHARE CERTIFICATE(S) AND SHOULD NOT SUBMIT ANY CERTIFICATE(S) UNTIL REQUESTED TO DO SO.

Vote Required

Recommendation of the Board of Directors

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE SHAREHOLDERS VOTE “FOR” THIS RESOLUTION.

PROPOSAL SIX

TO APPROVE AND ADOPT THE RESTATED M&A

General

We are proposing to approve, by a special resolution, subject to and conditional upon the passing of Proposals One, Two, Three and Four and all requisite class consents being obtained, and with effect immediately following effectiveness of the Share Capital Reduction, the adoption of the second amended and restated memorandum and articles of association of the Company in the form attached as Appendix A to the proxy statement in substitution for and to the exclusion of the existing amended and restated memorandum and articles of association of the Company to, among other things: (i) reflect the Share Capital Reduction, the Authorised Share Capital Increase, the Increase in Class B Voting Rights, and the Class B Conversion Rights; (ii) increase threshold for requisitioning a meeting to shareholders holding a majority of the voting rights; (iii) add an exclusive forum and jurisdiction clause; (iv) add prior written notice requirement for directors to vacate their office upon resignation and termination of their terms, and (v) make other consequential and minor updates, as more particularly described in the Restated M&A, and authorize the board of directors to do all other acts and things as the board considers necessary or desirable in connection with the adoption of the Restated M&A, including without limitation, attending to the necessary filing with the Registrar of Companies in the Cayman Islands.

Vote Required

This Proposal requires the affirmative (“FOR”) vote of a majority of not less than two-thirds of votes cast by shareholders as, being entitled to do so, vote in person or by proxy at the EGM. Unless otherwise instructed on the proxy or unless authority to vote is withheld, shares represented by executed proxies will be voted “FOR” this Proposal. Abstentions or broker non-votes, if any, will not be counted as votes cast, although abstentions and broker non-votes will be counted for purposes of determining whether there is a quorum present.

Recommendation of the Board of Directors

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE SHAREHOLDERS VOTE “FOR” THIS PROPOSAL.

PROPOSAL SEVEN

TO APPROVE THE AMENDMENT AND RESTATEMENT OF M&A FOLLOWING FIRST SHARE CONSOLIDATION

General

We are proposing to approve, by a special resolution, subject to and conditional upon the effectiveness of the first Share Consolidation implemented by the board of directors under Proposal Five, (a) to amend and restate the then effective memorandum and articles of association of the Company (the “Pre-Consolidation M&A”) by their deletion in their entirety and the substitution in their place with an amended and restated memorandum and articles of association (the “Post-Consolidation M&A”), being in the form of the Pre-Consolidation M&A, with amendments to the authorised share capital and par value descriptions to reflect the first Share Consolidation effected pursuant to Proposal Five; and (b) to authorise the Company’s registered office provider or other duly authorised representative to file these resolutions, the Board resolutions in relation to such Share Consolidation and the Post-Consolidation M&A with the Registrar of Companies in the Cayman Islands accordingly and authorise the board of directors to take all further actions and execute all further documents as may be necessary or advisable to carry out the intent of these resolutions.

Vote Required

Recommendation of the Board of Directors

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE SHAREHOLDERS VOTE “FOR” THIS PROPOSAL.

PROPOSAL EIGHT

ADJOURNMENT OF THE EGM TO A LATER DATE OR DATES, IF NECESSARY, TO PERMIT FURTHER SOLICITATION AND VOTE OF PROXIES IN THE EVENT THAT THERE ARE INSUFFICIENT VOTES FOR, OR OTHERWISE IN CONNECTION WITH, THE APPROVAL OF PROPOSAL ONE, PROPOSAL TWO, PROPOSAL THREE, PROPOSAL FOUR, PROPOSAL FIVE, PROPOSAL SIX, AND PROPOSAL SEVEN.

Proposal Eight, if adopted, will allow the chairman of the EGM to adjourn the EGM to a later date or dates to permit further solicitation of proxies. This Proposal will only be presented to our shareholders in the event that there are insufficient votes for, or otherwise in connection with, the approval of the other proposals.

If Proposal Eight is not approved by our shareholders, the chairman of the EGM may not be able to adjourn the EGM to a later date in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal One, Proposal Two, Proposal Three, Proposal Four, Proposal Five, Proposal Six, and Proposal Seven.

Vote Required

This Proposal requires the affirmative (“FOR”) vote of a simple majority of such shareholders as, being entitled to do so, vote in person or by proxy at the EGM. Unless otherwise instructed on the proxy or unless authority to vote is withheld, shares represented by executed proxies will be voted “FOR” this Proposal. Abstentions, if any, will not be counted as votes cast and will not affect the outcome of this Proposal, although they will be counted for purposes of determining whether there is a quorum present. If shareholders hold their shares through a broker, bank or other nominee and do not instruct them how to vote, the broker may have authority to vote the shares for this Proposal, which is considered a routine matter.

Recommendation of the Board of Directors

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE SHAREHOLDERS VOTE “FOR” THIS PROPOSAL.

OTHER MATTERS

As of the date of this Proxy Statement, the Board of Directors has no knowledge of any business which will be presented for consideration at the EGM other than the Share Capital Reduction, the Authorized Share Capital Increase, the Increase in Class B Voting Rights, the Class B Conversion Rights, the Shareholder Consolidations, the Adoption of the Restated M&A, the Amendment and Restatement of M&A Following First Share Consolidation, and the Adjournment of the EGM.

WHERE YOU CAN FIND MORE INFORMATION

The Company files reports and other documents with the SEC under the Exchange Act. The Company’s SEC filings made electronically through the SEC’s EDGAR system are available to the public at the SEC’s website at http://www.sec.gov.

Date: April 27, 2026	By Order of the Board of Directors

	/s/ Michael Lau
	Michael Lau
	Chief Executive Officer

Exhibit 99.2

Control Number:

Number of Shares:

Registered Shareholder:

Anbio Biotechnology

Friedrich-Ebert-Anlage 35-37, 60327

Frankfurt am Main, Germany

PROXY

Solicited on Behalf of the Board of Directors for the Meeting of Shareholders of Class A Ordinary Shares
on May 15, 2026 at 3 p.m., Germany Time

(May 15, 2026 at 9 a.m., Eastern Time)

The Meeting Materials for the Meeting of shareholders of Class A Ordinary Shares are available online at http://www.anbiobiotechnology.com. The undersigned hereby appoints Mr. Michael Lau as proxy with full power of substitution, to represent and to vote as set forth herein all the Class A Ordinary Shares of Anbio Biotechnology (the “Company”) which the undersigned is entitled to vote at the meeting of shareholders of Class A Ordinary Shares and any adjournments or postponements thereof, as designated below. If no designation is made, the proxy, when properly executed, will be voted “FOR” in Items 2, 3, 4, 5, and 6.

Proposal 1		[Intentionally Omitted]

Proposal 2		By an ordinary resolution, subject to and conditional upon the passing of the resolutions set out in Proposal One, Proposal Three, Proposal Four and Proposal Six, and with effect immediately following the effectiveness of the Share Capital Reduction, to increase the Company’s authorised share capital from:

		(i)	US$0.50 divided into 500,000,000 shares of par value US$0.000000001 each, comprising of 400,000,000 Class A Ordinary Shares of par value US$0.000000001 each and 100,000,000 Class B Ordinary Shares of par value US$0.000000001 each, to

		(ii)	US$3,000 divided into 3,000,000,000,000 shares of par value US$0.000000001 each, comprising of 800,000,000,000 Class A Ordinary Shares, 200,000,000,000 Class B Ordinary Shares, 1,000,000,000,000 Class C Ordinary Shares of par value US$0.000000001 each (the “Class C Ordinary Shares”) and 1,000,000,000,000 preference shares of par value US$0.000000001 each (the “Preference Shares”)

☐ For

☐ Against

☐ Abstain

Proposal 3

By an ordinary resolution, subject to and conditional upon the passing of the resolutions set out in Proposal One, Proposal Two, Proposal Four and Proposal Six and all requisite class consents being obtained, and with effect immediately following effectiveness of the Share Capital Reduction, to approve an increase in the voting rights attaching to the Class B Ordinary Shares from fifty (50) votes per Class B Ordinary Share to five hundred (500) votes per Class B Ordinary Share as set forth in the Restated M&A (as defined below) (the “Increase in Class B Voting Rights”)

☐ For

☐ Against

☐ Abstain

Proposal 4

By an ordinary resolution, subject to and conditional upon the passing of the resolutions set out in Proposals One to Three and Proposal Six and all requisite class consents being obtained, and with effect immediately following effectiveness of the Share Capital Reduction, to approve an alteration of the rights attaching to the Class B Ordinary Shares, such that each Class B Ordinary Share shall be convertible into Class A Ordinary Share(s) in accordance with the terms of the Restated M&A (the “Class B Conversion Rights”).

☐ For

☐ Against

☐ Abstain

Proposal 5

By an ordinary resolution, subject to and conditional upon all requisite class consents being obtained: (i) to approve one or more share consolidations of the Company’s issued and unissued Class A Ordinary Shares at a ratio of not less than two (2)-for-one (1) and not more than ten-thousand (10,000)-for-one (1) or the maximum consolidation ratio then permitted under applicable Nasdaq rules and requirements aggregately (the “Range”), with the exact ratio to be set as a whole number within the Range and the exact date to be determined by the board of directors of the Company in its sole discretion within three years after the date of passing of these resolutions (each a “Share Consolidation” and collectively, the “Share Consolidations”) provided that the aggregate ratio across all such Share Consolidations shall not exceed ten-thousand (10,000)-for-one (1) or such lower cap as imposed by Nasdaq at the time of implementation and that no fractional share shall arise from the Share Consolidations; (ii) to authorise the Company to round up any fractional shares resulting from the Share Consolidations to the nearest whole Class A Ordinary Share; and (iii) to authorise the board of directors to, at their sole and absolute discretion, implement one or more Share Consolidations, determine the exact consolidation ratio and the exact effective date of each such Share Consolidation, instruct the registered office provider or transfer agent of the Company to complete the necessary corporate record(s) and filing(s) to reflect the Share Consolidation(s) and do all other such acts and things as the board considers necessary or desirable for the purposes of the transactions contemplated by the Share Consolidation(s) (the “Share Consolidation Authorisation”).

☐ For

☐ Against

☐ Abstain

Proposal 6

By a special resolution, subject to and conditional upon the passing of Proposals One, Two, Three and Four and all requisite class consents being obtained, and with effect immediately following effectiveness of the Share Capital Reduction, to adopt the second amended and restated memorandum and articles of association of the Company (the “Restated M&A”) in the form attached as Appendix A to the proxy statement accompanying this notice in substitution for and to the exclusion of the existing amended and restated memorandum and articles of association of the Company to, among other things: (i) reflect the Share Capital Reduction, the Authorised Share Capital Increase, the Increase in Class B Voting Rights, and the Class B Conversion Rights; (ii) increase threshold for requisitioning a meeting to shareholders holding a majority of the voting rights; (iii) add an exclusive forum and jurisdiction clause; (iv) add prior written notice requirement for directors to vacate their office upon resignation and termination of their terms, and (v) make other consequential and minor updates, and authorise the board of directors to do all other acts and things as the board considers necessary or desirable in connection with the adoption of the Restated M&A, including without limitation, attending to the necessary filing(s) with the Registrar of Companies in the Cayman Islands (the “Adoption of the Restated M&A”).

☐ For

☐ Against

☐ Abstain

In his discretion, the proxy is authorized to vote upon any other matters which may properly come before the Meeting, or any adjournment or postponement thereof.

THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.

Dated: ____________________________________, 2026

_______________________________________________
Signature

_______________________________________________
Signature (Joint Owners)

Please date and sign name exactly as it appears hereon. Executors, administrators, trustees, etc. should so indicate when signing. If the shareholder is a corporation, the full corporate name should be inserted and the proxy signed by an officer of the corporation indicating his/her title

[SEE VOTING INSTRUCTIONS ON REVERSE SIDE]

VOTING INSTRUCTIONS

Please sign, date and mail this Proxy Card promptly to the following address in the enclosed postage-paid envelope:

Proxy Team

Transhare Corporation

Address: 17755 North US Highway 19, Suite # 140, Clearwater FL 33764

Telephone: (303) 662-1112

You may sign, date, scan and email your scanned Proxy Card to Proxy@Transhare.com

You may vote online through the Internet: www.Transhare.com click on Vote Your Proxy Enter Your Control Number:

If you vote your proxy on the Internet, you do not need to mail back or email your Proxy Card.

The Proxy Statement and the form of Proxy Card are available at www.transhare.com.

Consent to electronic delivery of proxy material: __________________________(email address).

Exhibit 99.3

Control Number:

Number of Shares:

Registered Shareholder:

Anbio Biotechnology

Friedrich-Ebert-Anlage 35-37, 60327

Frankfurt am Main, Germany

PROXY

Solicited on Behalf of the Board of Directors for the Extraordinary General Meeting of Shareholders
To Be Held Immediately Following the Meeting of the Shareholders of the Class A Ordinary Shares

The Meeting Materials for the Extraordinary General Meeting of shareholders are available online at http://www.anbiobiotechnology.com. The undersigned hereby appoints Mr. Michael Lau as proxy with full power of substitution, to represent and to vote as set forth herein all the ordinary shares of Anbio Biotechnology (the “Company”) which the undersigned is entitled to vote at the Extraordinary General Meeting of Shareholders and any adjournments or postponements thereof, as designated below. If no designation is made, the proxy, when properly executed, will be voted “FOR” in Items 1, 2, 3, 4, 5, 6, 7 and 8.

Proposal 1

By a special resolution, subject to and conditional upon the passing of the resolutions set out in Proposal Two to Proposal Four and Proposal Six, to approve a reduction in the Company’s authorised share capital from (i) US$50,000 divided into 500,000,000 shares of a par value of US$0.0001 each, comprising of 400,000,000 class A ordinary shares of a par value of US$0.0001 each and 100,000,000 class B ordinary shares of a par value of US$0.0001 each, to (ii) US$0.50 divided into 500,000,000 shares of par value US$0.000000001 each, comprising of 400,000,000 Class A Ordinary Shares of par value US$0.000000001 each (the “Class A Ordinary Shares”) and 100,000,000 Class B Ordinary Shares of par value US$0.000000001 each (the “Class B Ordinary Shares”), by way of reduction of the par value of each authorised share in the capital of the Company (including all issued shares) from US$0.0001 to US$0.000000001 (the “Share Capital Reduction”).

☐ For

☐ Against

☐ Abstain

Proposal 2

By an ordinary resolution, subject to and conditional upon the passing of the resolutions set out in Proposal One, Proposal Three, Proposal Four and Proposal Six, and with effect immediately following the effectiveness of the Share Capital Reduction, to increase the Company’s authorised share capital from:

		(i)	US$0.50 divided into 500,000,000 shares of par value US$0.000000001 each, comprising of 400,000,000 Class A Ordinary Shares of par value US$0.000000001 each and 100,000,000 Class B Ordinary Shares of par value US$0.000000001 each, to

		(ii)	US$3,000 divided into 3,000,000,000,000 shares of par value US$0.000000001 each, comprising of 800,000,000,000 Class A Ordinary Shares, 200,000,000,000 Class B Ordinary Shares, 1,000,000,000,000 Class C Ordinary Shares of par value US$0.000000001 each (the “Class C Ordinary Shares”) and 1,000,000,000,000 preference shares of par value US$0.000000001 each (the “Preference Shares”)

☐ For

☐ Against

☐ Abstain

Proposal 3

☐ For

☐ Against

☐ Abstain

Proposal 4

☐ For

☐ Against

☐ Abstain

Proposal 5

☐ For

☐ Against

☐ Abstain

Proposal 6

☐ For

☐ Against

☐ Abstain

Proposal 7

By a special resolution, subject to and conditional upon the effectiveness of the first Share Consolidation implemented by the board of directors under Proposal Five, (a) to amend and restate the then effective memorandum and articles of association of the Company (the “Pre-Consolidation M&A”) by their deletion in their entirety and the substitution in their place with an amended and restated memorandum and articles of association (the “Post-Consolidation M&A”), being in the form of the Pre-Consolidation M&A, with amendments to the authorised share capital and par value descriptions to reflect the first Share Consolidation effected pursuant to Proposal Five; and (b) to authorise the Company’s registered office provider or other duly authorised representative to file these resolutions, the Board resolutions in relation to such Share Consolidation and the Post-Consolidation M&A with the Registrar of Companies in the Cayman Islands accordingly and authorise the board of directors to take all further actions and execute all further documents as may be necessary or advisable to carry out the intent of these resolutions (the “Amendment And Restatement of M&A Following First Share Consolidation”).

☐ For

☐ Against

☐ Abstain

Proposal 8

By an ordinary resolution, to adjourn the EGM to a later date or dates for any purpose, including to solicit additional proxies if there are insufficient votes at the time of the EGM to approve the proposals described above (the “Adjournment Proposal”).

☐ For

☐ Against

☐ Abstain

In his discretion, the proxy is authorized to vote upon any other matters which may properly come before the Meeting, or any adjournment or postponement thereof.

THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.

Dated: ____________________________________, 2026

_______________________________________________

Signature

_______________________________________________

Signature (Joint Owners)

[SEE VOTING INSTRUCTIONS ON REVERSE SIDE]

VOTING INSTRUCTIONS

Please sign, date and mail this Proxy Card promptly to the following address in the enclosed postage-paid envelope:

Proxy Team

Transhare Corporation

Address: 17755 North US Highway 19, Suite # 140, Clearwater FL 33764

Telephone: (303) 662-1112

You may sign, date, scan and email your scanned Proxy Card to Proxy@Transhare.com

You may vote online through the Internet: www.Transhare.com click on Vote Your Proxy Enter Your Control Number:

If you vote your proxy on the Internet, you do not need to mail back or email your Proxy Card.

The Proxy Statement and the form of Proxy Card are available at www.transhare.com.

Consent to electronic delivery of proxy material: __________________________(email address).

Exhibit 99.4

COMPANIES ACT (AS AMENDED)

COMPANY LIMITED BY SHARES

SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION

ANBIO BIOTECHNOLOGY

(adopted by Special Resolutions passed on _________ 2026)

COMPANIES ACT (AS AMENDED)

COMPANY LIMITED BY SHARES

SECOND AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION

ANBIO BIOTECHNOLOGY

(adopted by a Special Resolution passed on _________ 2026)

The name of the Company is Anbio Biotechnology.

The registered office of the Company will be at the offices of Vistra (Cayman) Limited, P.O. Box 31119, Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman, KY1 - 1205, Cayman Islands or at such other place as the Board of Directors may from time to time determine.

The objects for which the Company is established are unrestricted and the Company shall have full power and authority to carry out any object not prohibited by law as provided by Section 7(4) of the Companies Act.

The Company shall have and be capable of exercising all the functions of a natural person of full capacity irrespective of any question of corporate benefit as provided by Section 27(2) of the Companies Act.

The Company will not trade in the Cayman Islands with any person, firm or corporation except in furtherance of the business of the Company carried on outside the Cayman Islands, provided that nothing in this Memorandum of Association shall be construed as to prevent the Company from effecting and concluding contracts in the Cayman Islands, and exercising in the Cayman Islands all of its powers necessary for the carrying on of its business outside the Cayman Islands.

The liability of each member is limited to the amount from time to time unpaid on such member’s shares.

The authorised share capital of the Company is US$3,000.00 divided into 3,000,000,000,000 shares of US$0.000000001 par value each, comprising of 800,000,000,000 Class A Ordinary Shares of US$0.000000001 par value each, and 200,000,000,000 Class B Ordinary Shares of US$0.000000001 par value each, 1,000,000,000,000 Class C Ordinary Shares of US$0.000000001 par value each and 1,000,000,000,000 preference shares of US$0.000000001 par value each. Insofar as is permitted by law and the Company’s articles of association (the “Articles”), the Company shall have the power to redeem, purchase or redesignate any of its shares and to increase or reduce the said share capital and to issue any part of its capital, whether original, redeemed or increased with or without any preference, priority or special privilege or subject to any postponement of rights or to any conditions or restrictions and so that unless the conditions of issue shall otherwise expressly provide every issue of shares whether stated to be ordinary, preference or otherwise shall be subject to the powers hereinbefore provided.

The Company may exercise the power contained in Section 206 of the Companies Act to deregister in the Cayman Islands and be registered by way of continuation in another jurisdiction.

Capitalised terms that are not defined in this Memorandum of Association bear the meanings given to those terms in the Articles.

COMPANIES ACT (AS AMENDED)

COMPANY LIMITED BY SHARES

SECOND AMENDED AND RESTATED ARTICLES OF ASSOCIATION

ANBIO BIOTECHNOLOGY

(adopted by a Special Resolution passed on _______2026)

TABLE OF CONTENTS

ARTICLE		PAGE
TABLE A; DEFINITIONS AND INTERPRETATION		1
COMMENCEMENT OF BUSINESS		4
SITUATION OF REGISTERED OFFICE		4
CERTIFICATES FOR SHARES		4
SHARES		5
RIGHTS ATTACHING TO ORDINARY SHARES		6
TRANSFER OF SHARES		7
REDEMPTION, PURCHASE AND SURRENDER OF SHARES		8
TREASURY SHARES		8
VARIATION OF RIGHTS OF SHARES		9
COMMISSION ON SALE OF SHARES		9
NON-RECOGNITION OF TRUSTS		9
LIEN ON SHARES		10
CALL ON SHARES		10
FORFEITURE OF SHARES		11
TRANSMISSION OF SHARES		11
ALTERATION OF SHARE CAPITAL		12
CLOSING REGISTER OF MEMBERS, FIXING RECORD DATE		12
GENERAL MEETINGS		13
NOTICE OF GENERAL MEETINGS		13
PROCEEDINGS AT GENERAL MEETINGS		14
VOTES OF MEMBERS		15
PROXIES		15
WRITTEN RESOLUTIONS OF MEMBERS		16
DIRECTORS		17
DIRECTORS’ INTERESTS		17
ALTERNATE DIRECTORS		18
POWERS AND DUTIES OF DIRECTORS		19
MANAGEMENT		19
MANAGING DIRECTORS		20
PROCEEDINGS OF DIRECTORS		20
WRITTEN RESOLUTIONS OF DIRECTORS		21
VACATION OF OFFICE OF DIRECTOR		21
APPOINTMENT AND REMOVAL OF DIRECTORS		21
PRESUMPTION OF ASSENT		21
SEAL		21
OFFICERS		22
DIVIDENDS, DISTRIBUTIONS AND RESERVES		22
SHARE PREMIUM ACCOUNT		23
CAPITALISATION		23
BOOKS OF ACCOUNT		24
AUDIT		24
NOTICES		24
WINDING UP		25
INDEMNITY		25
DISCLOSURE		26
FINANCIAL YEAR		26
AMENDMENTS TO MEMORANDUM AND ARTICLES OF ASSOCIATION		26
TRANSFER BY WAY OF CONTINUATION		26
CAYMAN ISLANDS DATA PROTECTION		26
EXCLUSIVE JURISDICTION AND FORUM		27

COMPANIES ACT (AS AMENDED)

COMPANY LIMITED BY SHARES

SECOND AMENDED AND RESTATED ARTICLES OF ASSOCIATION

ANBIO BIOTECHNOLOGY

(adopted by a Special Resolution passed on _________ 2026)

TABLE A; DEFINITIONS AND INTERPRETATION

In these Articles, Table A in the Schedule to the Companies Act does not apply and, unless there be something in the subject or context inconsistent therewith, the following words and expressions shall have the meanings set out below:

“Articles”	these articles of association of the Company, as amended from time to time by Special Resolution;

“Auditor”	the auditor or auditors for the time being of the Company;

“Board of Directors”	the Directors acting together as a board of directors or as a committee appointed by that board of directors;

“Chairperson”	means the chairperson of the Board of Directors for the time being (and “Deputy Chairperson” shall have a corresponding meaning);

“Class” or “Classes”	means any class or classes of Shares as may from time to time be issued by the Company;

“Class A Ordinary Share”	means a Class A ordinary share in the capital of the Company and having the rights provided for in these Articles;

“Class B Ordinary Share”	means a Class B ordinary share in the capital of the Company and having the rights provided for in these Articles;

“Class C Ordinary Share”	means a Class C ordinary share in the capital of the Company and having the rights provided for in these Articles;

“Commission”	means the Securities and Exchange Commission of the United States or any other federal agency for the time being administering the Securities Act;

“Communication Facilities”	means video, video-conferencing, internet or online conferencing applications, telephone or tele-conferencing and/or any other video-communications, internet or online conferencing application or telecommunications facilities by means of which all persons participating in a meeting are capable of hearing and being heard by each other;

“Companies Act”	the Companies Act (as amended);

“Company”	the above-named company;

“Company’s Website”	means the main corporate/investor relations website of the Company, the address or domain name of which has been disclosed in any registration statement filed by the Company with the Commission in connection with its initial public offering, or which has otherwise been notified to Members;

“debenture”	means debenture stock, mortgages, bonds and any other such securities of the Company whether constituting a charge on the assets of the Company or not;

“Designated Stock Exchange”	means any stock exchange in the United States on which any Shares or other securities of the Company are listed for the time being;

“Designated Stock Exchange Rules”	means the relevant code, rules and regulations, as amended, from time to time, applicable as a result of the listing of any Shares or other securities of the Company on the Designated Stock Exchange;

“Director”	a director of the Company for the time being;

“Electronic Record”	has the same meaning as in the Electronic Transactions Act;

“Electronic Transactions Act”	the Electronic Transactions Act (as amended);

“Member”	any person registered in the Register of Members as the holder of one or more Shares;

“Memorandum”	the Memorandum of Association of the Company, as amended and restated from time to time by Special Resolution;

“Ordinary Resolution”	a resolution passed by a simple majority of the votes of such Members as, being entitled to do so, vote in person or, where proxies are allowed, by proxy, at a general meeting or a written resolution signed by all the Members for the time being entitled to receive notice of, attend and vote at a general meeting or in such other manner as may be permitted under the Companies Act from time to time;

“Ordinary Shares”	means the Class A Ordinary Shares, the Class B Ordinary Shares and the Class C Ordinary Shares, collectively;

“paid up”	paid up as to the par value and any premium payable in respect of the issue of any Shares and includes credited as paid up;

“person”	any natural person, firm, company, joint venture, partnership, corporation, association or other entity (whether or not having separate legal personality) or any of them as the context so requires;

“Preference Share”	means a preference share in the capital of the Company;

“Register of Members”	the register of Members to be kept pursuant to these Articles;

“Registered Office”	the registered office of the Company for the time being;

“Seal”	the common seal of the Company including any duplicate seal;

“Secretary”	any person appointed by the Board of Directors to perform any of the duties of the secretary of the Company, including a joint, assistant or deputy secretary;

“Securities Act”	means the Securities Act of 1933 of the United States, as amended, or any similar federal statute and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time;

“Share”	a share in the capital of the Company of any Class including a fraction of such share;

“Share Premium Account”	the share premium account established in accordance with these Articles and the Companies Act;

“signed”	includes an electronic signature and a signature or representation of a signature affixed by mechanical means;

“Special Resolution”	has the same meaning as in the Companies Act;

“Treasury Shares”	Shares that were previously issued but were purchased, redeemed, surrendered or otherwise acquired by the Company and not cancelled;

“United States”	means the United States of America, its territories, its possessions and all areas subject to its jurisdiction; and

“Virtual Meeting”	means any general meeting of the Members (or any meeting of the holders of any Class of Shares) at which the Members (and any other permitted participants of such meeting, including without limitation the chairperson of the meeting and any Directors) are permitted to attend and participate solely by means of Communication Facilities.

In these Articles, unless there be something in the subject or context inconsistent with such construction:

(a)

words importing the singular number shall include the plural number and vice versa;

(b)

words importing a gender shall include all genders;

(c)

words importing persons shall include companies, corporations, partnerships, trusts, associations and other bodies of persons, whether or not having separate legal personality;

(d)

the word “may” shall be construed as permissive and the word “shall” shall be construed as imperative;

(e)

the word “year” shall mean calendar year, the word “quarter” shall mean calendar quarter and the word “month” shall mean calendar month;

(f)

the words “including”, “include”, “in particular” or any similar expression are to be construed without limitation;

(g)

a reference to a “dollar” or “$” is a reference to the legal currency of the United States;

(h)

a reference to any enactment includes a reference to any modification or re-enactment thereof for the time being in force;

(i)

a reference to any meeting (whether of the Board of Directors, a committee appointed by the Board of Directors or the Members or any class of Members) includes any adjournment of that meeting;

(j)

the term “clear days”, in relation to a period of notice, means the period excluding the day when the notice is received or deemed to be received and the day for which it is given or on which it is to take effect;

(k)

Sections 8 and 19 of the Electronic Transactions Act shall not apply; and

(l)

a reference to “written” or “in writing” includes a reference to all modes of representing or reproducing words in visible form, including in the form of an Electronic Record.

Subject to the two preceding Articles, any words defined in the Companies Act shall, if not inconsistent with the subject or context, bear the same meaning in these Articles.

The table of contents to, and the headings in, these Articles are for convenience of reference only and are to be ignored in construing these Articles.

COMMENCEMENT OF BUSINESS

The business of the Company may be commenced as soon after incorporation as the Board of Directors shall see fit, notwithstanding that part only of the shares may have been allotted.

The Board of Directors may pay, out of the capital or any other monies of the Company, all expenses incurred in or about the formation and establishment of the Company including the expenses of registration.

SITUATION OF REGISTERED OFFICE

The Registered Office shall be at such address in the Cayman Islands as the Board of Directors shall from time to time determine. The Company, in addition to the Registered Office, may establish and maintain such other offices and places of business and agencies in such places as the Board of Directors may from time to time determine.

CERTIFICATES FOR SHARES

The Shares will be issued in fully registered, book-entry form. Certificates will not be issued unless the Board of Directors determines otherwise. All share certificates, if any, shall specify the Share or Shares held by that person, provided that in respect of a Share or Shares held jointly by several persons the Company shall not be bound to issue more than one certificate, and delivery of a certificate for a Share to one of several joint holders shall be sufficient delivery to all. All certificates for Shares shall be delivered personally or sent through the post addressed to the Member entitled thereto at the Member’s registered address as appearing in the Register of Members.

Every share certificate of the Company shall bear any legends required under the applicable laws, including the Securities Act.

10.

Any two or more certificates representing Shares of any one Class held by any Member may at the Member’s request be cancelled and a single new certificate for such Shares issued in lieu on payment (if the Board of Directors shall so require) of one dollar (US$1.00) or such smaller sum as the Board of Directors shall determine.

11.

If a share certificate shall be damaged or defaced or alleged to have been lost, stolen or destroyed, a new certificate representing the same Shares may be issued to the relevant Member upon request, subject to delivery up of the old certificate or (if alleged to have been lost, stolen or destroyed) compliance with such conditions as to evidence and indemnity and the payment of out-of-pocket expenses of the Company in connection with the request as the Board of Directors may think fit.

12.

In the event that Shares are held jointly by several persons, any request may be made by any one of the joint holders and if so made shall be binding on all of the joint holders.

13.

The Board of Directors may impose such restrictions as they think necessary on the offer and sale of any Shares.

14.

Subject to these Articles, all Shares for the time being unissued shall be under the control of the Board of Directors who may issue, allot and dispose of or grant options over the same and issue warrants or similar instruments with respect thereto to such persons, on such terms, and with or without preferred, deferred or other rights and restrictions, whether in regard to dividend, voting, return of capital or otherwise, and otherwise in such manner as they may think fit. Without limiting the foregoing, the Board of Directors may from time to time and without the approval of Members, issue Preference Shares with such preferred or other rights, all or any of which may be greater than the rights of Ordinary Shares, as the Board of Directors may determine. For such purposes, the Board of Directors may reserve an appropriate number of Shares for the time being unissued.

15.

Subject to the Companies Act, and without prejudice to any rights previously conferred on the holders of existing Shares, any share or fraction of a share in the Company’s share capital may be issued either at a premium or at par, and with such preferred, deferred, other special rights, or restrictions, whether in regard to dividend, voting, return of share capital or otherwise, as the Board of Directors may from time to time determine, and any share may be issued by the Board of Directors on the terms that it is, or at the option of the Board of Directors is liable, to be redeemed or purchased by the Company whether out of capital in whole or in part or otherwise. No Share may be issued at a discount except in accordance with the Companies Act.

16.

The Board of Directors may in their absolute discretion refuse to accept any application for Shares and may accept any application in whole or in part.

17.

The Company may on any issue of Shares deduct any sales charge or subscription fee from the amount subscribed for the Shares.

18.

The Board of Directors shall keep or cause to be kept a Register of Members as required by the Companies Act at such place or places as the Board of Directors may from time to time determine. In the absence of any such determination, the Register of Members shall be kept at the Registered Office.

19.

The Company shall not issue Shares to bearer.

20.

The Board of Directors may issue fractions of a Share and, if so issued, a fraction of a Share shall be subject to and carry the corresponding fraction of liabilities (whether with respect to nominal or par value, premium, calls or otherwise howsoever), limitations, preferences, privileges, qualifications, restrictions, rights (including, without prejudice to the foregoing generality, voting and participation rights) and other attributes of a Share. If more than one fraction of a Share is issued to or acquired by the same Member, such fractions shall be accumulated.

21.

The premium arising on all issues of Shares shall be held in the Share Premium Account established in accordance with these Articles.

22.

Payment for Shares shall be made at such time and place and to such person on behalf of the Company as the Board of Directors may from time to time determine. Payment for any Shares shall be made in such currency as the Board of Directors may determine from time to time, provided that the Board of Directors shall have the discretion to accept payment in any other currency or in kind or a combination of cash and in kind.

RIGHTS ATTACHING TO ORDINARY SHARES

23.

Except as otherwise provided in these Articles, holders of Class A Ordinary Shares and Class B Ordinary Shares shall at all times vote together as one class on all resolutions submitted to a vote by the Members. At a general meeting, each Class A Ordinary Share shall entitle the holder thereof to one (1) vote on all matters subject to vote at general meetings of the Company, and each Class B Ordinary Share shall entitle the holder thereof to five hundred (500) votes on all such matters. Class C Ordinary Shares shall be non-voting shares and shall not confer rights to vote at any general meeting of the Company.

24.

Each Class A Ordinary Share and each Class C Ordinary Share shall confer upon the holder thereof the right to receive dividends as provided for in these Articles. Class B Ordinary Shares do not confer upon the holders thereof any rights to receive dividends.

25.

On a winding up of the Company:

(a)

each Class A Ordinary Share and each Class C Ordinary Share shall confer upon the holder thereof the right to repayment of capital in accordance with these Articles and the right to participate in the profits or surplus assets of the Company in accordance with these Articles; and

(b)

each Class B Ordinary Share shall confer upon the holder thereof the right to repayment of capital in accordance with these Articles but shall confer no other right to participate in the profits or surplus assets of the Company.

26.

Class B Ordinary Shares shall not have any economic interest (save for the right to repayment of capital on a winding up, as set forth in Article 25(b)).

27.

28.

29.

30.

Except as set out in Articles 23 to 29, the Ordinary Shares shall rank pari passu with one another and shall have the same rights, preferences, privileges and restrictions.

TRANSFER OF SHARES

31.

Provided that such transfer complies with the Designated Stock Exchange Rules, a Member may transfer Shares to another person by completing an instrument of transfer:

(a)

in a form prescribed by the Designated Stock Exchange; or

(b)

otherwise in any common form or form approved by the Board of Directors which is executed by or on behalf of that Member, where the Shares are fully paid, or by or on behalf of that Member and the transferee, where the Shares are partly-paid or unpaid.

32.

Where the Shares in question are not listed on a Designated Stock Exchange or are otherwise not subject to the Designated Stock Exchange Rules, the Board of Directors may, in its absolute discretion, decline to register any transfer of Shares that have not been fully paid up or are subject to a lien in favour of the Company. The Board of Directors may also decline to register any transfer of any Share, unless:

(a)

the instrument of transfer is lodged with the Company, accompanied by the certificate (if any) for the Shares to which it relates and such other evidence as the Board of Directors may reasonably require to show the right of the transferor to make the transfer;

(b)

the instrument of transfer is in respect of only one Class of Shares;

(c)

the instrument of transfer is properly stamped, if required;

(d)

the Share transferred is fully paid and free of any lien in favour of the Company;

(e)

a fee of such maximum sum as the Designated Stock Exchange may determine to be payable, or such lesser sum as the Board of Directors may from time to time require, is paid to the Company in respect thereof; and

(f)

in the case of a transfer to joint holders, the number of joint holders to whom the Share is to be transferred does not exceed four.

33.

The registration and transfer of Shares may be suspended at such times and for such periods as the Board of Directors may from time to time determine, subject to the requirements of the Designated Stock Exchange Rules (including as to notice).

34.

All instruments of transfer that are registered shall be retained by the Company, but any instrument of transfer which the Board of Directors may decline to register shall (except in any case of fraud) be returned to the person depositing the same.

35.

Notwithstanding any other provision of these Articles, title to any Shares listed on a stock exchange that is an “approved stock exchange” (as defined in the Companies Act) may be evidenced and transferred in accordance with the laws applicable to, and the rules and regulations of, the relevant approved stock exchange that are or shall be applicable to such listed Shares. For the purposes of this Article, the laws applicable to an approved stock exchange include the laws of the jurisdiction under which the relevant approved stock exchange is established insofar as they would apply to an entity established under such laws which has listed shares on such approved stock exchange.

REDEMPTION, PURCHASE AND SURRENDER OF SHARES

36.

Subject to the Companies Act, the Company may:

(a)

issue Shares on terms that they are to be redeemed or are liable to be redeemed at the option of the Company and/or the Member on such terms and in such manner as the Board of Directors may, before the issue of such Shares, determine;

(b)

purchase its own Shares (including any redeemable Shares) on such terms and in such manner and terms as have been approved by the Board or by the Members by Ordinary Resolution, or are otherwise authorised by these Articles; and

(c)

make a payment in respect of the redemption or purchase of Shares in any manner authorised by the Companies Act, including out of its capital, profits or the proceeds of a fresh issue of Shares.

37.

Unless the Board of Directors determines otherwise, any Share in respect of which notice of redemption has been given shall not be entitled to participate in the profits of the Company in respect of the period after the date specified as the date of redemption in the notice of redemption.

38.

The redemption or purchase of any Share shall not be deemed to give rise to the redemption or purchase of any other Share.

39.

The Board of Directors may when making payments in respect of a redemption or purchase of Shares, if authorised by the terms of issue of the Shares being redeemed or purchased or with the agreement of the holder of such Shares, make such payment either in cash or in specie.

40.

Subject to the Companies Act, the Company may accept the surrender for no consideration of any fully paid Share (including any redeemable Share) on such terms and in such manner as the Board of Directors may determine.

TREASURY SHARES

41.

Shares that the Company purchases, redeems or acquires (by way of surrender or otherwise) may, at the option of the Company, be cancelled immediately or held as Treasury Shares in accordance with the Companies Act. In the event that the Board of Directors does not specify that the relevant Shares are to be held as Treasury Shares, such Shares shall be cancelled.

42.

No dividend may be declared or paid, and no other distribution (whether in cash or otherwise) of the Company’s assets (including any distribution of assets to Members on a winding up) may be declared or paid in respect of a Treasury Share.

43.

The Company shall be entered in the Register of Members as the holder of the Treasury Shares, provided that:

(a)

the Company shall not be treated as a Member for any purpose and shall not exercise any right in respect of the Treasury Shares, and any purported exercise of such a right shall be void; and

(b)

a Treasury Share shall not be voted, directly or indirectly, at any meeting of the Company and shall not be counted in determining the total number of issued shares at any given time, whether for the purposes of these Articles or the Companies Act, save that an allotment of Shares as fully paid bonus shares in respect of Treasury Shares is permitted and Shares allotted as fully paid bonus shares in respect of Treasury Shares shall be treated as Treasury Shares.

44.

Treasury Shares may be disposed of by the Company on any terms and conditions determined by the Board of Directors. The Board of Directors may determine to cancel a Treasury Share or transfer a Treasury Share on such terms as it thinks proper (including for nil consideration).

VARIATION OF RIGHTS OF SHARES

45.

If at any time the share capital of the Company is divided into different Classes of Shares, the rights attached to any Class (unless otherwise provided by the terms of issue of the Shares of that Class) may, whether or not the Company is being wound up, be varied or abrogated:

(a)

by, or with the approval of, the Board of Directors without the consent of the holders of the Shares of that Class if the Board of Directors determines that the variation or abrogation is not materially adverse to the interests of those Members; or

(b)

otherwise only with the consent in writing of the holders of a majority of the issued Shares of that Class or with the sanction of an Ordinary Resolution passed at a separate meeting of the holders of the Shares of that Class.

46.

The provisions of these Articles relating to general meetings shall apply, mutatis mutandis, to every class meeting of the holders of one Class of Shares, except that the necessary quorum shall be the presence in person or by proxy of one or more Members holding Shares of the relevant Class that represent not less than one-third of the voting rights of the issued and outstanding issued Shares of the relevant Class carrying the right to vote at such meeting, provided that if at any adjourned meeting of such holders a quorum as above defined is not present in person or represented by proxy, those holders of Shares of the relevant Class who are present in person or represented by proxy shall form a quorum.

47.

For the purposes of Articles 45 and 46, the Board of Directors may treat all Classes of Shares, or any two or more Classes of Shares, as forming a single Class if it considers that each Class would be affected in the same way by the proposal or proposals under consideration. In any other case, the Board of Directors shall treat all Classes of Shares as separate Classes.

48.

The rights of the holders of the Shares of any Class shall not, unless otherwise expressly provided by the terms of issue or other rights attaching to the Shares of that Class, be deemed to be materially adversely varied or abrogated by the creation or issue of further Shares ranking in priority to, pari passu with or subsequent to those Shares, the creation or issue of Shares having preferred or other rights or the redemption or purchase of Shares of any other Class by the Company.

COMMISSION ON SALE OF SHARES

49.

The Company may in so far as the Companies Act from time to time permits pay a commission to any person in consideration of his subscribing or agreeing to subscribe whether absolutely or conditionally for any Shares. Such commissions may be satisfied by the payment of cash or the lodgement of fully or partly paid-up Shares or partly in one way and partly in the other. The Company may also on any issue of Shares pay such brokerage as may be lawful.

NON-RECOGNITION OF TRUSTS

50.

No person shall be recognised by the Company as holding any Share upon any trust, and the Company shall not be bound by or recognise (even when having notice thereof) any equitable, contingent, future or partial interest in any Share, or (except as otherwise provided by these Articles or as required by law) any other right in respect of any Share except an absolute right thereto in the registered holder, provided that, notwithstanding the foregoing, the Company shall be entitled to recognise any such interests as shall be determined by the Board of Directors.

LIEN ON SHARES

51.

The Company shall have a first and paramount lien on all Shares (whether fully paid-up or not) registered in the name of a Member (whether solely or jointly with others) for all debts, liabilities or engagements to or with the Company (whether presently payable or not) by such Member or the Member’s estate, either alone or jointly with any other person, whether a Member or not, but the Board of Directors may at any time declare any Share to be wholly or in part exempt from the provisions of this Article. The registration of a transfer of any such Share shall operate as a waiver of the Company’s lien thereon. The Company’s lien on a Share shall also extend to any amount payable in respect of that Share.

52.

The Company may sell, in such manner as the Board of Directors thinks fit, any Shares on which the Company has a lien, if a sum in respect of which the lien exists is presently payable, and is not paid within fourteen (14) clear days after notice has been given to the holder of the Shares, or to the person entitled to it in consequence of the death or bankruptcy of the holder, demanding payment and stating that if the notice is not complied with the Shares may be sold.

53.

To give effect to any such sale, the Board of Directors may authorise any person to execute an instrument of transfer of the Shares sold to, or in accordance with the directions of, the purchaser. The purchaser or the purchaser’s nominee shall be registered as the holder of the Shares comprised in any such transfer, and the purchaser shall not be bound to see to the application of the purchase money, nor shall the purchaser’s title to the Shares be affected by any irregularity or invalidity in the sale or the exercise of the Company’s power of sale under these Articles.

54.

The net proceeds of such sale, after payment of costs, shall be applied in payment of such part of the amount in respect of which the lien exists as is presently payable and any residue shall (subject to a like lien for sums not presently payable as existed upon the Shares before the sale) be paid to the person entitled to the Shares at the date of the sale.

CALL ON SHARES

55.

Subject to the terms of the allotment, the Board of Directors may from time to time make calls upon the Members in respect of any monies unpaid on their Shares (whether in respect of par value or premium), and each Member shall (subject to receiving at least fourteen (14) days’ notice specifying the time or times of payment) pay to the Company at the time or times so specified the amount called on the Shares. A call may be revoked or postponed as the Board of Directors may determine. A call may be required to be paid by instalments. A person upon whom a call is made shall remain liable for calls made upon them notwithstanding the subsequent transfer of the Shares in respect of which the call was made.

56.

A call shall be deemed to have been made at the time when the resolution of the Board of Directors authorising such call was passed.

57.

The joint holders of a Share shall be jointly and severally liable to pay all calls in respect thereof.

58.

If a call remains unpaid after it has become due and payable, the person from whom it is due shall pay interest on the amount unpaid from the day it became due and payable until it is paid at such rate as the Board of Directors may determine, but the Board of Directors may waive payment of the interest wholly or in part.

59.

An amount payable in respect of a Share on allotment or at any fixed date, whether on account of the par value of the Share or premium or otherwise, shall be deemed to be a call and if it is not paid all the provisions of these Articles shall apply as if that amount had become due and payable by virtue of a call.

60.

The Board of Directors may issue Shares with different terms as to the amount and times of payment of calls, or the interest to be paid.

61.

The Board of Directors may, if it thinks fit, receive an amount from any Member willing to advance all or any part of the monies uncalled and unpaid upon any Shares held by such Member, and may (until the amount would otherwise become payable) pay interest at such rate as may be agreed upon between the Company and the Member paying such amount in advance.

62.

No such amount paid in advance of calls shall entitle the Member paying such amount to any portion of a dividend declared in respect of any period prior to the date upon which such amount would, but for such payment, become payable.

FORFEITURE OF SHARES

63.

If a call remains unpaid after it has become due and payable, the Board of Directors may give to the person from whom it is due not less than fourteen (14) clear days’ notice requiring payment of the amount unpaid together with any interest which may have accrued. The notice shall specify where payment is to be made and shall state that if the notice is not complied with the Shares in respect of which the call was made will be liable to be forfeited.

64.

If the notice is not complied with any Share in respect of which it was given may, before the payment required by the notice has been made, be forfeited by a resolution of the Board of Directors. Such forfeiture shall include all dividends or other monies declared payable in respect of the forfeited Share and not paid before the forfeiture.

65.

A forfeited Share may be sold, re-allotted or otherwise disposed of on such terms and in such manner as the Board of Directors thinks fit and at any time before a sale, re-allotment or disposition the forfeiture may be cancelled on such terms as the Board of Directors thinks fit. Where, for the purposes of its disposal, a forfeited Share is to be transferred to any person, the Board of Directors may authorise some person to execute an instrument of transfer of the Share in favour of that person.

66.

A person any of whose Shares have been forfeited shall cease to be a Member in respect of them and shall surrender to the Company for cancellation the certificate for the Shares forfeited and shall remain liable to pay to the Company all monies which at the date of forfeiture were payable by such person to the Company in respect of those Shares together with interest, but such person’s liability shall cease if and when the Company shall have received payment in full of all monies due and payable by such person in respect of those Shares.

67.

A certificate in writing under the hand of one Director or officer of the Company that a Share has been forfeited on a specified date shall be conclusive evidence of the fact as against all persons claiming to be entitled to the Share. The certificate shall (subject to the execution of any instrument of transfer) constitute a good title to the Share and the person to whom the Share is disposed of shall not be bound to see to the application of the purchase money, if any, nor shall such person’s title to the Share be affected by any irregularity or invalidity in the proceedings in reference to the forfeiture, sale or disposal of the Share.

68.

The provisions of these Articles as to forfeiture shall apply in the case of non-payment of any sum which, by the terms of issue of a Share, becomes payable at a fixed time, whether on account of the par value of the Share or by way of premium as if it had been payable by virtue of a call duly made and notified.

TRANSMISSION OF SHARES

69.

In case of the death of a Member, the survivors or survivor (where the deceased was a joint holder) and the executors or administrators of the deceased where the deceased was the sole or only surviving holder, shall be the only persons recognised by the Company as having title to the deceased’s interest in the Shares, but nothing in this Article shall release the estate of the deceased holder whether sole or joint from any liability in respect of any Share solely or jointly held by the deceased.

70.

Any guardian of an infant Member and any curator bonis or other legal representative of a Member under legal disability and any person entitled to a share in consequence of the death or bankruptcy of a Member shall, upon producing such evidence of title as the Board of Directors may require, have the right either to be registered as the holder of the Share or to make such transfer thereof as the deceased or bankrupt Member could have made, but the Board of Directors shall in either case have the same right to refuse or suspend registration as they would have had in the case of a transfer of the Shares by the infant or by the deceased or bankrupt Member before the death or bankruptcy or by the Member under legal disability before such disability.

71.

A person so becoming entitled to a Share in consequence of the death or bankruptcy of a Member shall have the right to receive and may give a discharge for all dividends and other money payable or other advantages due on or in respect of the Share, but such person shall not be entitled to receive notice of or to attend or vote at meetings of the Company, or save as aforesaid, to any of the rights or privileges of a Member unless and until such person shall be registered as a Member in respect of the Share, provided always that the Board of Directors may at any time give notice requiring any such person to elect either to be registered or to transfer the Share and, if the notice is not complied with within ninety (90) days, the Board of Directors may thereafter withhold all dividends or other monies payable or other advantages due in respect of the Share until the requirements of the notice have been complied with.

ALTERATION OF SHARE CAPITAL

72.

The Company may from time to time by Ordinary Resolution increase its share capital by such sum to be divided into Shares of such amounts as the resolution shall prescribe.

73.

All new Shares shall be subject to the provisions of these Articles with reference to transfer, transmission and otherwise.

74.

Subject to the Companies Act, the Company may by Special Resolution from time to time reduce its share capital in any way, and in particular, without prejudice to the generality of the foregoing power, may:

(a)

cancel any paid-up share capital which is lost, or which is not represented by available assets; or

(b)

pay off any paid-up share capital which is in excess of the requirements of the Company,

and may, if and so far as is necessary, alter the Memorandum by reducing the amounts of its share capital and of its Shares accordingly.

75.

The Company may from time to time by Ordinary Resolution alter (without reducing) its share capital by:

(a)

consolidating and dividing all or any of its share capital into Shares of larger amount than its existing Shares;

(b)

sub-dividing its Shares, or any of them, into Shares of smaller amount than that fixed by the Memorandum so, however, that in the sub-division the proportion between the amount paid and the amount, if any, unpaid on each reduced Share shall be the same as it was in the case of the Share from which the reduced Share is derived; or

(c)

cancelling any Shares which, at the date of the passing of the Ordinary Resolution, have not been taken, or agreed to be taken by any person, and diminishing the amount of its authorised share capital by the amount of the Shares so cancelled.

76.

Any consolidation, division or sub-division of undertaken in respect of any Class of Shares shall not be deemed to give rise to the consolidation, division or sub-division any other Class of Shares.

CLOSING REGISTER OF MEMBERS, FIXING RECORD DATE

77.

For the purpose of determining the Members who are entitled to receive notice of, or to vote at, any meeting of Members, or the Members who are entitled to receive payment of any dividend or other distribution, or in order to make a determination of the Members for any other purpose, the Board of Directors may, after notice has been given by advertisement in an appointed newspaper or any other newspaper or in any other way permitted under the Designated Stock Exchange Rules, the rules and regulations of the Commission or any other competent regulatory authority or otherwise under applicable law, provide that the Register of Members shall be closed for transfers for a stated period which shall not in any case exceed forty (40) days.

78.

In lieu of or apart from closing the Register of Members, the Board of Directors may fix in advance or in arrears a date as the record date for any determination of Members entitled to notice of, or to vote at, any meeting of Members, or for the purpose of determining the Members entitled to receive payment of any dividend or other distribution or in order to make a determination of the Members for any other purpose, and any record date so fixed may be before or after the date on which the board resolution fixing the record date is passed.

79.

If no record date is fixed for the determination of Members entitled to notice of, or to vote at, a meeting of Members, or for the purpose of determining the Members entitled to receive payment of a dividend or other distribution, the date on which notice of the meeting is mailed or the date on which the resolution of the Board of Directors declaring such dividend or other distribution is passed, as the case may be, shall be the record date for such determination of Members. When a determination of Members entitled to vote at any meeting has been made in the manner provided in the preceding Article, such determination shall apply to any adjournment thereof.

GENERAL MEETINGS

80.

The Board of Directors may proceed to convene a general meeting whenever they think fit, including for the purposes of considering a liquidation of the Company, and they shall convene a general meeting on the requisition of one or more Members holding at the date of the deposit of the requisition Shares representing a majority of the votes attaching to the issued and outstanding Shares that as at the date of the deposit carry the right to vote at general meetings of the Company.

81.

The requisition:

(a)

must be in writing, state the objects of the meeting and set out in full the text of each resolution to be considered at the meeting;

(b)

must be signed by each requisitionist and deposited at the Registered Office; and

(c)

may consist of several documents in like form each signed by one or more requisitionists.

82.

If the Board of Directors does not within thirty (30) days from the date of the deposit of the requisition duly proceed to convene a general meeting, the requisitionists, or any of them representing more than one-half of the total voting rights of all of them, may themselves convene a general meeting, but any meeting so convened shall not be held after the expiration of forty-five (45) days after the expiration of the aforementioned thirty (30) day period.

83.

A general meeting convened as aforesaid by requisitionists shall be convened in the same manner as nearly as possible as that in which general meetings are convened by the Board of Directors. A general meeting may be convened in the Cayman Islands or at such other location as the Board of Directors thinks fit.

NOTICE OF GENERAL MEETINGS

84.

At least five (5) calendar days’ notice at least specifying the place, the day and the hour of any general meeting and the general nature of the business to be conducted at the general meeting, shall be given in the manner hereinafter mentioned to such persons as are under these Articles or the conditions of issue of the Shares held by them entitled to receive notices from the Company. If the Board of Directors determines that prompt Member action is advisable, it may shorten the notice period for any general meeting to such period as the Board of Directors considers reasonable in the circumstances.

85.

A general meeting shall, notwithstanding that it is called by shorter notice than that specified in the preceding Article, be deemed to have been duly called with regard to the length of notice if it is so agreed:

(a)

in the case of a meeting called as the annual general meeting, by all the Members entitled to attend and vote thereat; and

(b)

in the case of any other general meeting, by one or more Members holding Shares representing not less than two-thirds of all votes attaching to the issued and outstanding Shares carrying the right to vote at a general meeting.

86.

In every notice calling a general meeting, there shall appear:

(a)

a statement that any Member entitled to attend and vote is entitled to appoint one or more proxies to attend such general meeting and vote instead of such Member and that a proxy need not also be a Member; and

(b)

the full text of each Special Resolution to be considered at such general meeting (if any).

87.

The accidental omission to give notice to, or the non-receipt of notice by, any person entitled to receive notice shall not invalidate the proceedings at any general meeting.

PROCEEDINGS AT GENERAL MEETINGS

88.

No business except for the appointment of a chairperson for the meeting shall be transacted at any general meeting unless a quorum is present. Save as otherwise provided in these Articles a quorum shall be the presence, in person or by proxy, of one or more Members holding Shares that represent one-third of the voting rights of the issued and outstanding Shares carrying the right to vote at such general meeting.

89.

Save as otherwise provided for in these Articles, if within half an hour from the time appointed for the meeting a quorum is not present, the meeting, if convened on the requisition of or by Members, shall be dissolved. In any other case it shall stand adjourned to the same day in the next week, at the same time and place or to such other day and at such other time and place as the Board of Directors may determine and if at such adjourned meeting a quorum is not present within fifteen (15) minutes from the time appointed for holding the meeting, the Members present shall be a quorum.

90.

The Board of Directors may, in its discretion, (i) permit attendance at and participation in any general meeting of the Company by means of Communication Facilities and/or (ii) determine that any general shall, through the aid of Communication Facilities, be held in more than one place. Without limiting the generality of the foregoing, the Board of Directors may determine that any general meeting may be held as a Virtual Meeting. The notice of any general meeting at which Communication Facilities will be utilised (including any Virtual Meeting) shall disclose the Communication Facilities that will be used, including the procedures to be followed by any person who wishes to utilise such Communication Facilities for the purposes of attending, participating in and/or voting at such meeting.

91.

The Chairperson (if any) or, if absent, the Deputy Chairperson (if any) of the Board of Directors, or, failing them, some other Director nominated by the Board of Directors shall preside as chairperson at every general meeting, but if at any meeting neither the Chairperson nor the Deputy Chairperson nor such other Director be present within fifteen (15) minutes after the time appointed for holding the meeting, or if neither of them be willing to act as chairperson of the meeting, the Directors present shall choose some Director present to be chairperson of the meeting or if no Directors be present, or if all the Directors present decline to take the chair, the Members present shall choose some Member present to be chairperson of the meeting.

92.

The chairperson of any general meeting (including any Virtual Meeting) shall be entitled to attend and participate at any such general meeting by means of Communication Facilities, and to act as the chairperson of such general meeting, in which event the following provisions shall apply:

(a)

The chairperson of the meeting shall be deemed to be present at the meeting; and

(b)

If the Communication Facilities are interrupted or fail for any reason to enable the chairperson of the meeting to hear and be heard by all other persons participating in the meeting, then the other Directors present at the meeting shall choose another Director present to act as chairperson of the meeting for the remainder of the meeting; provided that if no other Director is present at the meeting, or if all the Directors present decline to take the chair, then the meeting shall be automatically adjourned to the same day in the next week and at such time and place as shall be decided by the Board of Directors.

93.

The chairperson of the meeting may with the consent of any meeting at which a quorum is present (and shall if so directed by the meeting) adjourn the meeting from time to time and from place to place but no business shall be transacted at any adjourned meeting except business which might lawfully have been transacted at the meeting from which the adjournment took place. When a meeting is adjourned for fourteen (14) days or more, at least five (5) days’ notice specifying the place, the day and the hour of the adjourned meeting shall be given as in the case of the original meeting but it shall not be necessary to specify in such notice the nature of the business to be transacted at the adjourned meeting. Save as aforesaid, it shall not be necessary to give any notice of an adjournment or of the business to be transacted at an adjourned meeting.

94.

The Board of Directors may cancel or postpone any duly convened general meeting at any time prior to such meeting, except for general meetings requisitioned by the Members in accordance with these Articles, for any reason or for no reason, and shall, as soon as practicable after the determination to cancel or postpone such meeting is made, give notice in writing to the Members of such cancellation or postponement. A postponement may be for a stated period of any length or indefinitely as the Board of Directors may determine.

95.

At any general meeting, a resolution put to the vote of the meeting shall be decided by a poll and not on a show of hands.

96.

A poll shall be taken in such manner as the chairperson of the meeting directs, and the result of the poll shall be deemed to be the resolution of the meeting. If, through the aid of Communication Facilities, the meeting is held in more than one place, the chairperson of the meeting may appoint scrutineers in more than one place, but if the chairperson of the meeting considers that the poll cannot be monitored effectively at the meeting, the chairperson of the meeting may adjourn the meeting to a place (or places), date and time at which the chairperson of the meeting believes it will be possible for the poll to be monitored effectively.

97.

All questions submitted to a meeting shall be decided by an Ordinary Resolution except where a greater majority is required by these Articles or by the Companies Act. In the case of an equality of votes, the chairperson of the meeting shall be entitled to a second or casting vote.

98.

A poll shall be taken forthwith or at such time as the chairperson of the meeting directs.

VOTES OF MEMBERS

99.

Subject to any rights and restrictions for the time being attached to any Share, on a poll every Member present in person or by proxy at the meeting shall have one (1) vote for each Class A Ordinary Share held by such Member and five hundred (500) votes for each Class B Ordinary Share held by such Member. Class C Ordinary Shares shall be non-voting shares and shall not confer any rights to vote at any general meeting of the Company.

100.

In the case of joint holders of a Share, the vote of the senior holder who tenders a vote, whether in person or by proxy, shall be accepted to the exclusion of the votes of the other joint holders, and, for this purpose, seniority shall be determined by the order in which the names stand in the Register of Members in respect of the Shares.

101.

A Member who has appointed special or general attorneys or a Member who is subject to a disability may vote on a poll, by such Member’s attorney, committee, receiver, curator bonis or other person in the nature of a committee, receiver, or curator bonis appointed by a court and such attorney, committee, receiver, curator bonis or other person may on a poll vote by proxy; provided that such evidence as the Board of Directors may require of the authority of the person claiming to vote shall, unless otherwise waived by the Board of Directors, have been deposited with the Company not less than forty-eight (48) hours before the time for holding the meeting or adjourned meeting at which such person claims to vote.

102.

No objection shall be raised to the qualification of any voter except at the meeting or adjourned meeting at which the vote objected to is given or tendered, and every vote not disallowed at such meeting shall be valid for all purposes. Any such objection made in due time shall be referred to the chairperson of the meeting, whose decision shall be final and conclusive.

103.

Votes may be given either personally or by proxy and a Member entitled to more than one vote need not, if the Member votes, use all their votes or cast all the votes the Member uses in the same way.

PROXIES

104.

Any person (whether a Member or not) may be appointed to act as a proxy. Each Member, other than a recognised clearing house (or its nominee(s)) or depositary (or its nominee(s)), may only appoint one proxy on a poll. The instrument appointing a proxy shall be in writing under the hand of the appointor or of his attorney duly authorised in writing or, if the appointor is a corporation, either under Seal or under the hand of an officer or attorney duly authorised.

105.

The instrument appointing a proxy shall be deposited at such place as is specified for that purpose in the notice convening the meeting or in any instrument of proxy sent out by the Company:

(a)

not less than 48 hours before the time for holding the meeting or adjourned meeting at which the person named in the instrument proposes to vote; or

(b)

in the case of a poll taken more than forty-eight (48) hours after it is demanded, be deposited as aforesaid after the poll has been demanded and not less than twenty-four (24) hours before the time appointed for the taking of the poll; or

(c)

where the poll is not taken forthwith but is taken not more than forty-eight (48) hours after it was demanded, be delivered at the meeting at which the poll was demanded to the chairperson of the meeting or to the Secretary or to any Director,

provided that the Board of Directors may in the notice convening the meeting, or in an instrument of proxy sent out by the Company, direct that the instrument appointing a proxy may be deposited at such other time (no later than the time for holding the meeting or adjourned meeting) at such place as is specified for that purpose in the notice convening the meeting, or in any instrument of proxy sent out by the Company. The chairperson of the meeting may in any event at his discretion direct that an instrument of proxy shall be deemed to have been duly deposited. An instrument of proxy that is not deposited in the manner permitted shall be invalid.

106.

An instrument of proxy:

(a)

shall be in any usual or common form or in such other form as the Board of Directors may approve;

(b)

shall be deemed to confer authority to vote on any amendment of a resolution put to the general meeting for which it is given as the proxy thinks fit; and

(c)

may be expressed to be for a particular meeting or generally until revoked and, in the case of a proxy given for a particular meeting, shall be valid for any adjournment of the general meeting for which it is given unless earlier revoked.

107.

The Board of Directors may at the expense of the Company send to the Members instruments of proxy (with or without prepaid postage for their return) for use at any general meeting, either in blank or nominating in the alternative any one or more of the Directors or any other persons. If for the purpose of any meeting invitations to appoint as proxy a person or one of a number of persons specified in the invitations are issued at the expense of the Company, such invitations shall be issued to all (and not to some only) of the Members entitled to be sent a notice of the meeting and to vote thereat by proxy.

108.

A vote given in accordance with the terms of an instrument of proxy shall be valid notwithstanding the death or insanity of the principal or the revocation of the instrument of proxy, or of the authority under which the instrument of proxy was executed, provided that no intimation in writing of such death, insanity, revocation or transfer shall have been received by the Company before commencement of the meeting or adjourned meeting at which the instrument of proxy is used.

109.

Anything which under these Articles a Member may do by proxy that Member may also do by a duly appointed attorney. The provisions of these Articles relating to proxies and instruments appointing proxies apply, mutatis mutandis, to any such attorney and the instrument appointing that attorney.

110.

Any Member which is a corporation, partnership other body corporate may, by a resolution of its directors or other governing body, authorise such person as it thinks fit to act as its representative at any meeting or meetings of the Company. The person so authorised shall be entitled to exercise the same powers on behalf of such corporation, partnership or other body corporate as the corporation, partnership or other body corporate could exercise if it were a Member who was an individual and such corporation, partnership or other body corporate shall for the purposes of these Articles be deemed to be present in person at any such meeting if a person so authorised is present.

111.

If a recognised clearing house (or its nominee(s)) or depositary (or its nominee(s)) is a Member of the Company it may, by resolution of its directors or other governing body or by power of attorney, authorise such person(s) as it thinks fit to act as its representative(s) at any general meeting of the Company or of any Class of Members provided that, if more than one person is so authorised, the authorisation shall specify the number and Class of Shares in respect of which each such person is so authorised. A person so authorised pursuant to this Article shall be entitled to exercise the same powers on behalf of the recognised clearing house (or its nominee(s)) or depositary (or its nominee(s)) which he represents as that recognised clearing house (or its nominee(s)) or depositary (or its nominee(s)) could exercise if it were an individual Member holding the number and Class of Shares specified in such authorisation.

WRITTEN RESOLUTIONS OF MEMBERS

112.

A resolution in writing signed by all the Members for the time being entitled to receive notice of, attend and vote at a general meeting shall be as valid and effective as a resolution passed at a general meeting duly convened and held and may consist of several documents in the like form each signed by one or more of the Members. The foregoing shall be without limitation to any other manner of passing a resolution of the Members in writing that may be permitted under the Companies Act.

DIRECTORS

113.

The Company shall at all times have not less than one Director. Subject to the foregoing and the requirements of the Designated Stock Exchange Rules, the Company may by Ordinary Resolution impose any maximum or minimum number of Directors required to hold office at any time and vary such limits from time to time and, unless and until any minimum or maximum number of Directors is so imposed, the minimum number of Directors shall be one and there shall be no maximum.

114.

Each Director shall be entitled to such remuneration as approved by the Board of Directors and this may be in addition to such remuneration as may be payable under any other Article. The Directors shall be entitled to be paid for their travelling, hotel and other expenses properly incurred by them in going to, attending and returning from meetings of the Board of Directors, or any committee of the Board of Directors, or general meetings of the Company, or otherwise in connection with the business of the Company, or to receive such fixed allowance in respect thereof as may be determined by the Board of Directors from time to time, or a combination partly of one such method and partly the other. The Board of Directors may, in addition to such remuneration as aforesaid, grant special remuneration to any Director who, being called upon, shall perform any special or extra services to or at the request of the Company.

DIRECTORS’ INTERESTS

115.

A Director may hold any other office or place of profit under the Company (other than the office of Auditor) in conjunction with their office of Director on such terms as to remuneration, tenure of office and otherwise as the Board of Directors may determine.

116.

Any Director may act independently or through the Director’s firm in a professional capacity for the Company, and the Director or the firm shall be entitled to remuneration for professional services as if the Director were not a Director, provided that nothing herein contained shall authorise a Director or the Director’s firm to act as Auditor to the Company.

117.

A Director need not be a Member but shall be entitled to receive notice of and attend all general meetings.

118.

No Director or intending Director shall be disqualified by their office from contracting with the Company either as vendor, purchaser or otherwise, nor shall any such contract or any contract or arrangement entered into by or on behalf of the Company in which any Director is in any way interested be liable to be avoided, nor shall any Director so contracting or being so interested be liable to account to the Company for any profit realised by any such contract or arrangement by reason of such Director holding that office or of the fiduciary relationship thereby established, but the nature of the Director’s interest must be declared by such Director at the meeting of the Board of Directors at which the question of entering into the contract or arrangement is first taken into consideration, or if the Director was not at the date of that meeting interested in the proposed contract or arrangement, then at the next meeting of the Board of Directors held after such Director becomes so interested, and in a case where the Director becomes interested in a contract or arrangement after it is made, then at the first meeting of the Board of Directors held after such Director becomes so interested.

119.

A Director who is in any way, whether directly or indirectly, interested in a contract or proposed contract with the Company shall declare (whether by specific or general notice) the nature of their interest at a meeting of the Board of Directors. Subject to the Designated Stock Exchange Rules, a Director may vote in respect of any contract or proposed contract or arrangement notwithstanding that such Director may be interested therein and if such Director does so their vote shall be counted and such Director may be counted in the quorum at any meeting of the Board of Directors at which any such contract or proposed contract or arrangement shall come before the meeting for consideration.

120.

A general notice given to the Board of Directors by any Director to the effect that he is a member or director of (or is otherwise interested in) any specified company or firm and is to be regarded as interested in any contract or transaction which may thereafter be made with that company or firm shall be deemed a sufficient declaration of interest in regard to any contract so made or transaction so consummated.

121.

Where proposals are under consideration concerning the appointment (including fixing or varying the terms of appointment) of two or more Directors to offices or employments with the Company or any company in which the Company is interested, such proposals may be divided and considered in relation to each Director separately and in such cases each of the Directors concerned shall be entitled to vote (and be counted in the quorum) in respect of each resolution except that concerning the Director’s own appointment.

122.

Any Director may continue to be or become a director, managing director, manager or other officer or Member of any company promoted by the Company or in which the Company may be interested, and no such Director shall be accountable for any remuneration or other benefits received by the Director as a director, managing director, manager or other officer or Member of any such other company. The Board of Directors may exercise the voting power conferred by the shares in any other company held or owned by the Company or exercisable by them as directors of such other company, in such manner in all respects as it thinks fit (including the exercise thereof in favour of any resolution appointing themselves or any of them directors, managing directors or other officers of such company, or voting or providing for the payment of remuneration to the directors, managing directors or other officers of such company).

ALTERNATE DIRECTORS

123.

Each Director shall have the power to appoint another Director or any other person to act as alternate Director in the Director’s place at any meeting of the Board of Directors at which the Director is unable to be present and at the Director’s discretion to remove such alternate Director. On such appointment being made the alternate Director shall (except as regards the power to appoint an alternate Director) be subject in all respects to the terms and conditions existing with reference to the other Directors and each alternate Director, whilst acting in the place of an absent Director, shall exercise and discharge all the functions, powers and duties of the Director being represented. Any Director who is appointed as alternate Director shall be entitled at a meeting of the Board of Directors to cast a vote on behalf of their appointor in addition to the vote to which such Director is entitled in their own capacity as a Director, and shall also be considered as two Directors for the purpose of forming a quorum at a meeting of the Board of Directors. Any person appointed as an alternate Director shall automatically vacate such office as an alternate Director if and when the Director by whom the alternate Director has been appointed vacates their office of Director. The remuneration of an alternate Director shall be payable out of the remuneration of the Director appointing such alternate Director and shall be agreed between them.

124.

Every instrument appointing an alternate Director shall be in such form as the Board of Directors may approve.

125.

The appointment and removal of an alternate Director shall take effect when lodged with the Company or delivered at a meeting of the Board of Directors.

POWERS AND DUTIES OF DIRECTORS

126.

The business of the Company shall be managed by the Board of Directors, who may exercise all such powers of the Company as are not by the Companies Act or by these Articles required to be exercised by the Company in general meeting, subject nevertheless to any regulations of these Articles, to the Companies Act, and to such regulations being not inconsistent with the aforesaid regulations or provisions as may be prescribed by the Company in general meeting, but no regulations made by the Company in general meeting shall invalidate any prior act of the Board of Directors which would have been valid if such regulations had not been made. The general powers given by this Article shall not be limited or restricted by any special authority or power given to the Board of Directors by any other Article.

127.

The Board of Directors may from time to time and at any time by power of attorney appoint any company, firm or person or any fluctuating body of persons, whether nominated directly or indirectly by the Board of Directors, to be the attorney or attorneys of the Company for such purposes and with such powers authorities and discretions (not exceeding those vested in or exercisable by the Board of Directors under these Articles) and for such period and subject to such conditions as they may think fit, and any such appointment may contain such provisions for the protection and convenience of persons dealing with any such attorneys as the Board of Directors may think fit, and may also authorise any such attorney to sub-delegate all or any of the powers, authorities and discretions vested in such attorney. The Board of Directors may also appoint any person to be the agent of the Company for such purposes and with such powers, authorities and discretions (not exceeding those vested in or exercisable by the Board of Directors under these Articles) and for such period and on such conditions as they determine, including authority for the agent to delegate all or any of their powers.

128.

Subject to applicable law and the requirements of Designated Stock Exchange Rules, the Board of Directors may, from time to time, adopt, institute, amend, modify or revoke the corporate governance policies or initiatives of the Company, which shall set out the guiding principles and policies of the Company with respect to corporate governance related matters.

129.

All cheques, promissory notes, drafts, bills of exchange and other negotiable or transferable instruments drawn by the Company, and all receipts for monies paid to the Company shall be signed, drawn, accepted, endorsed or otherwise executed, as the case may be, in such manner as the Board of Directors shall from time to time determine.

130.

The Board of Directors shall cause minutes to be made of:

(a)

all appointments of officers made by the Board of Directors;

(b)

the names of the Directors present at each meeting of the Board of Directors and of any committee of the Board of Directors; and

(c)

all resolutions and proceedings of all general meetings of the Company and of the Board of Directors and of any committee of the Board of Directors.

Any such minutes, if purporting to be signed by the chairperson of the meeting of the meeting at which the proceedings took place, or by the chairperson of the meeting of the next succeeding meeting, shall, unless the contrary be proved, be conclusive evidence of the proceedings.

131.

The Board of Directors may cause the Company to pay a gratuity or pension or allowance on retirement to any Director who has held any other salaried office or place of profit with the Company or to his widow or dependants and may make contributions to any fund and pay premiums for the purchase or provision of any such gratuity, pension or allowance.

132.

The Board of Directors may exercise all the powers of the Company to borrow money and hypothecate, mortgage, charge or pledge its undertaking, property, and assets or any part thereof, and to issue debentures, debenture stock or other securities, whether outright or as collateral security for any debt liability or obligation of the Company or of any third party.

MANAGEMENT

133.

The Board of Directors may from time to time provide for the management of the affairs of the Company in such manner as it shall think fit and the provisions contained in the three next following Articles shall not limit the general powers conferred by this Article.

134.

The Board of Directors from time to time and at any time may establish any committees, local boards or agencies for managing any of the affairs of the Company and may appoint any natural person or corporation to be a member of such committees or local boards and may appoint any managers or agents of the Company and may fix the remuneration of any such natural person or corporation.

135.

The Board of Directors from time to time and at any time may delegate to any such committee, local board, manager or agent any of the powers, authorities and discretions for the time being vested in the Board of Directors and may authorise the members for the time being of any such local board, or any of them to fill any vacancies therein and to act notwithstanding vacancies and any such appointment or delegation may be made on such terms and subject to such conditions as the Board of Directors may think fit and the Board of Directors may at any time remove any natural person or corporation so appointed and may annul or vary any such delegation, but no person dealing in good faith and without notice of any such annulment or variation shall be affected thereby.

136.

Any such delegates as aforesaid may be authorised by the Board of Directors to sub-delegate all or any of the powers, authorities, and discretions for the time being vested in them.

MANAGING DIRECTORS

137.

The Board of Directors may, from time to time, appoint one or more of their number (but not an alternate Director) to the office of managing director for such term and at such remuneration (whether by way of salary, or commission, or participation in profits, or partly in one way and partly in another) as they may think fit, but any such appointment shall ipso facto terminate if any managing director ceases for any reason to be a Director.

138.

The Board of Directors may entrust to and confer upon a managing director any of the powers exercisable by them upon such terms and conditions and with such restrictions as they may think fit and either collaterally with or to the exclusion of their own powers and may from time to time revoke, withdraw, alter or vary all or any of such powers.

PROCEEDINGS OF DIRECTORS

139.

The Board of Directors may meet together for the dispatch of business, adjourn and otherwise regulate their meetings, as they think fit. Questions and matters arising at any meeting shall be determined by a majority of votes. In the case of an equality of votes, the Chairperson shall have a second or casting vote. A Director may, and the Secretary on the requisition of a Director shall, at any time summon a meeting of the Directors.

140.

A Director or Directors may participate in any meeting of the Board of Directors, or of any committee appointed by the Board of Directors of which such Director or Directors are members, by means of Communication Facilities and such participation shall be deemed to constitute presence in person at the meeting.

141.

The quorum necessary for the transaction of the business at any meeting of the Board of Directors may be fixed by the Board of Directors and, unless so fixed, shall be two if there are two or more Directors, and shall be one if there is only one Director.

142.

The continuing Directors or a sole continuing Director may act notwithstanding any vacancies in their number, but if and so long as the number of Directors is reduced below the minimum number fixed by or in accordance with these Articles the continuing Directors or Director may act for the purpose of filling up vacancies in their number, or of summoning general meetings, but not for any other purpose. If there be no Directors or Director able or willing to act, then any two Members may summon a general meeting for the purpose of appointing Directors.

143.

The Board of Directors may from time to time elect and remove a Chairperson and, if they think fit, a Deputy Chairperson and determine the period for which they respectively are to hold office. The Chairperson or, failing them, the Deputy Chairperson shall preside at all meetings of the Board of Directors, but if there be no Chairperson or Deputy Chairperson, or if at any meeting the Chairperson or Deputy Chairperson be not present within fifteen (15) minutes after the time appointed for holding the same, the Directors present may choose one of their number to be chairperson of the meeting.

144.

A meeting of the Board of Directors for the time being at which a quorum is present shall be competent to exercise all powers and discretions for the time being exercisable by the Board of Directors.

145.

Without prejudice to the powers conferred by these Articles, the Board of Directors may delegate any of their powers to committees consisting of one or more persons who need not be Directors. such member or members of their body as they think fit. Persons on any such committee may include non-Directors so long as the majority of those persons are Directors. The delegation may be collateral with, or to the exclusion of, the Directors’ own powers. Any such delegation may be on such terms as the Board of Directors thinks fit, including provision for the committee itself to delegate to a sub-committee; save that any delegation must be capable of being revoked or altered by the Board of Directors at will. Any committee so formed shall, in the exercise of the powers so delegated, conform to any regulations that may be imposed on them by the Board of Directors. The meetings and proceedings of any such committee consisting of two or more Directors shall be governed by the provisions of these Articles regulating the meetings and proceedings of the Board of Directors so far as the same are applicable and are not superseded by any regulations made by the Board of Directors under the preceding sentence.

146.

Without limitation to the preceding Article, the Board of Directors may, by power of attorney or otherwise, delegate any of their powers to any director or employee of the Company or to any other person and may appoint any person to be an attorney, agent or authorised signatory of the Company on such condition as the Board of Directors may determine, provided that the delegation is not to the exclusion of their own powers and is capable of being revoked or altered by the Board of Directors at will.

147.

All acts done by any meeting of the Board of Directors, or of a committee of the Board of Directors or by any person acting as a Director, shall, notwithstanding it be afterwards discovered that there was some defect in the appointment of any such Director or person acting as aforesaid, or that they or any of them were disqualified, or had vacated office, or were not entitled to vote, be as valid as if every such person had been duly appointed, and was qualified and had continued to be a Director and had been entitled to vote.

WRITTEN RESOLUTIONS OF DIRECTORS

148.

A resolution in writing signed by all the Directors for the time being entitled to attend and vote at a meeting of the Board of Directors (an alternate Director being entitled to sign such a resolution on behalf of their appointor) shall be as valid and effective as a resolution passed at a meeting of the Board of Directors duly convened and held and may consist of several documents in the like form each signed by one or more of the Directors (or their alternates).

VACATION OF OFFICE OF DIRECTOR

149.

The office of a Director shall be vacated forthwith if that Director:

(a)

resigns or terminates their term with or without cause on not less than three months’ prior notice in writing to the Company given in accordance with the terms specified in a written agreement between the Company and the Director, if any;

(b)

becomes bankrupt or makes any arrangement or composition with such Director’s creditors generally;

(c)

was only appointed as a Director for a fixed term and such term expires without renewal, unless the contract with the director provides for the automatic renewal of the term and no notice of non-renewal or termination has been given in accordance with such contract;

(d)

dies or, in the opinion of a registered medical practitioner by whom that Director is being treated, is or becomes of unsound mind;

(e)

ceases to be a Director by virtue of, or becomes prohibited from being a Director by reason of, an order made under any provisions of any law or enactment;

(f)

is removed from office by notice addressed to such Director at their last known address and signed by all of the other Directors (not being less than two in number);

(g)

is absent (without being represented by an alternate Director appointed by him) from three consecutive meetings of the Board of Directors without special leave of absence from the Directors, and they pass a resolution that he has by reason of such absence vacated office; or

(h)

is removed from office by Ordinary Resolution.

APPOINTMENT AND REMOVAL OF DIRECTORS

150.

The Company may, by Ordinary Resolution, appoint any person to be a Director and may in like manner remove any Director and may appoint another person in the Director’s stead. Without prejudice to the power of the Company by Ordinary Resolution to appoint a person to be a Director, the Board of Directors may appoint any person as a Director, to fill a casual vacancy on the Board or as an addition to the existing Board.

151.

An appointment of a Director may be on terms that the Director shall automatically retire from office (unless he has sooner vacated office) at the next or a subsequent annual general meeting, or upon the occurrence of any event specified in a written agreement between the Company and the Director, if any, or upon the expiry of any period specified in a written agreement between the Company and the Director, if any; but no such term shall be implied in the absence of express provision. Any Director whose term of office expires without renewal shall be eligible for re-appointment by the Members or by the Board of Directors.

PRESUMPTION OF ASSENT

152.

A Director who is present at a meeting of the Board of Directors at which action on any Company matter is taken shall be presumed to have assented to the action taken unless the Director’s dissent shall be entered in the minutes of the meeting or unless the Director shall file their written dissent from such action with the person acting as the secretary of the meeting before the adjournment thereof or shall forward such dissent by registered mail to such person immediately after the adjournment of the meeting. Such right to dissent shall not apply to a Director who voted in favour of such action.

SEAL

153.

If a Seal is adopted, the Board of Directors shall provide for the safe custody of the Seal and the Seal shall never be used except by the authority of a resolution of the Board of Directors or under the authority of a Director or committee of the Board of Directors authorised by the Board of Directors in that behalf. The Board of Directors may keep for use outside the Cayman Islands a duplicate Seal. The Board of Directors may from time to time as they see fit (subject to the provisions of these Articles relating to share certificates) determine the persons and the number of such persons in whose presence the Seal or the facsimile thereof shall be used, and until otherwise so determined the Seal or any duplicate thereof shall not be affixed to any instrument other than in the presence of a Director or the Secretary, or of some other person duly authorised by the Board of Directors for such purpose.

154.

Notwithstanding the foregoing, a Secretary or any assistant Secretary shall have the authority to affix the Seal, or any duplicate Seal, to any instrument for the purposes of attesting authenticity of the matter contained therein but which does not create any obligation binding on the Company.

OFFICERS

155.

Subject to these Articles, the Board of Directors may from time to time appoint any natural person or corporation, whether or not a Director to hold such office in the Company as the Directors may think necessary for the administration of the Company, including but not limited to, chief executive officer, one or more other executive officers, president, one or more vice presidents, treasurer, assistant treasurer, manager or controller, and for such term and at such remuneration (whether by way of salary or commission or participation in profits or partly in one way and partly in another), and with such powers and duties as the Board of Directors may think fit. Any natural person or corporation so appointed by the Board of Directors may be removed by the Board of Directors.

156.

The Board of Directors may appoint any person to be a Secretary who shall hold office for such term, at such remuneration and upon such conditions and with such powers as they think fit. Any Secretary so appointed by the Board of Directors may be removed by the Board of Directors or by the Company by Ordinary Resolution. Anything required or authorised to be done by or to the Secretary may, if the office is vacant or there is for any other reason no Secretary capable of acting, be done by or to any assistant or deputy Secretary or if there is no assistant or deputy Secretary capable of acting, by or to any officer of the Company authorised generally or specially in that behalf by the Board of Directors, provided that any provisions of these Articles requiring or authorising a thing to be done by or to a Director and the Secretary shall not be satisfied by its being done by or to the same person acting both as Director and as, or in the place of, the Secretary.

157.

No person shall be appointed or hold office as Secretary who is:

(a)

the sole Director;

(b)

a corporation the sole director of which is the sole Director; or

(c)

the sole director of a corporation which is the sole Director.

DIVIDENDS, DISTRIBUTIONS AND RESERVES

158.

Subject to the Companies Act, these Articles, and the special rights and restrictions attaching to Shares of any Class, the Board of Directors may, in its absolute discretion, declare dividends and distributions on Shares in issue and authorise payment of the dividends or distributions out of the funds of the Company lawfully available therefor. No dividend or distribution shall be paid except out of the realised or unrealised profits of the Company, or out of the Share Premium Account, or as otherwise permitted by the Companies Act.

159.

The Board of Directors may, before declaring any dividends or distributions, set aside such sums as they think proper as a reserve or reserves which shall at the discretion of the Board of Directors, be applicable for any purpose of the Company and pending such application may, at the like discretion, be employed in the business of the Company.

160.

Except as otherwise provided by the rights and restrictions attached to Shares, or as otherwise determined by the Board of Directors, all dividends and distributions in respect of Shares shall be declared and paid according to the par value of the Shares that a Member holds. If any Share is issued on terms providing that it shall rank for dividend or distribution as from a particular date, that Share shall rank for dividend or distribution accordingly.

161.

The Board of Directors may deduct and withhold from any dividend or distribution otherwise payable to any Member all sums of money (if any) then payable by the Member to the Company on account of calls or otherwise or any monies which the Company is obliged by law to pay to any taxing or other authority.

162.

The Board of Directors may declare that any dividend or distribution be paid wholly or partly by the distribution of specific assets and in particular of shares, debentures or securities of any other company or in any one or more of such ways and, where any difficulty arises in regard to such distribution, the Board of Directors may settle the same as it thinks expedient and in particular may issue fractional Shares and fix the value for distribution of such specific assets or any part thereof and may determine that cash payments shall be made to any Member upon the basis of the value so fixed in order to adjust the rights of all Members and may vest any such specific assets in trustees as may seem expedient to the Directors.

163.

Any dividend, distribution, interest or other monies payable in cash in respect of Shares may be paid by wire transfer to the holder or by cheque or warrant sent through the post directed to the registered address of the holder or, in the case of joint holders, to the registered address of the holder who is first named on the Register of Members or to such person and to such address as such holder or joint holders may in writing direct. Every such cheque or warrant shall (unless the Board of Directors in its sole discretion otherwise determines) be made payable to the order of the person to whom it is sent. Any one of two or more joint holders may give effectual receipts for any dividends, bonuses, or other monies payable in respect of the Share held by them as joint holders.

164.

Any dividend or distribution which cannot be paid to a Member and/or which remains unclaimed after six (6) months from the date of declaration of such dividend or distribution may, in the discretion of the Board of Directors, be paid into a separate account in the Company’s name, provided that the Company shall not be constituted as a trustee in respect of that account and the dividend or distribution shall remain as a debt due to the Member. Any dividend or distribution which remains unclaimed after a period of six years from the date of declaration of such dividend or distribution shall be forfeited and shall revert to the Company.

165.

No dividend or distribution shall bear interest against the Company unless expressly provided for by the rights attaching to a particular Class of Shares and no dividend or distribution shall be paid on Treasury Shares.

SHARE PREMIUM ACCOUNT

166.

The Board of Directors shall establish an account on the books and records of the Company to be called the Share Premium Account and shall carry to the credit of such account from time to time a sum equal to the amount or value of the premium paid on the issue of any Share.

167.

There shall be debited to any Share Premium Account on the redemption or purchase of a Share the difference between the nominal value of such Share and the redemption or purchase price provided always that at the discretion of the Board of Directors such sum may be paid out of the profits of the Company or, if permitted by the Companies Act, out of capital.

CAPITALISATION

168.

Subject to the Companies Act, the Board of Directors may:

(a)

resolve to capitalise an amount standing to the credit of reserves (including a Share Premium Account, capital redemption reserve and profit and loss account), which is available for distribution;

(b)

appropriate the sum resolved to be capitalised to the Members in proportion to the nominal amount of Shares (whether or not fully paid) held by them respectively and apply that sum on their behalf in or towards:

(i)

paying up the amounts (if any) for the time being unpaid on Shares held by them respectively, or

(ii)

paying up in full unissued Shares or debentures of a nominal amount equal to that sum,

and allot the Shares or debentures, credited as fully paid, to the Members (or as they may direct) in those proportions, or partly in one way and partly in the other, but the Share Premium Account, the capital redemption reserve and profits which are not available for distribution may, for the purposes of this Article, only be applied in paying up unissued Shares to be allotted to Members credited as fully paid;

(c)

make any arrangements they think fit to resolve a difficulty arising in the distribution of a capitalised reserve and in particular, without limitation, where Shares or debentures become distributable in fractions the Board of Directors may deal with the fractions as it thinks fit;

(d)

authorise a person to enter (on behalf of all the Members concerned) into an agreement with the Company providing for either:

(i)

the allotment to the Members respectively, credited as fully paid, of Shares or debentures to which they may be entitled on the capitalisation; or

(ii)

the payment by the Company on behalf of the Members (by the application of their respective proportions of the reserves resolved to be capitalised) of the amounts or part of the amounts remaining unpaid on their existing Shares,

and any such agreement made under this authority being effective and binding on all those Members; and

(e)

generally do all acts and things required to give effect to such resolutions.

169.

Notwithstanding any provisions in these Articles and subject to the Companies Act, the Board of Directors may resolve to capitalise an amount standing to the credit of reserves (including the Share Premium Account, capital redemption reserve and profit and loss account) or otherwise available for distribution by applying such sum in paying up in full unissued Shares to be allotted and issued to:

(a)

employees, Directors or service providers of the Company or its affiliates upon exercise or vesting of any options or awards granted under any share incentive scheme or employee benefit scheme or other arrangement which relates to such persons that has been adopted or approved by the Board of Directors or the Members;

(b)

any trustee of any trust or administrator of any share incentive scheme or employee benefit scheme to whom shares are to be allotted and issued by the Company in connection with the operation of any share incentive scheme or employee benefit scheme or other arrangement which relates to such persons that has been adopted or approved by the Board of Directors or Members; or

(c)

service providers of the Company or its affiliates upon exercise or vesting of any options or awards granted under any share incentive scheme or employee benefit scheme or other arrangement which relates to such persons that has been adopted or approved by the Board of Directors or the Members.

BOOKS OF ACCOUNT

170.

The Board of Directors shall cause proper books of account to be kept with respect to all sums of money received and expended by the Company and the matters in respect of which the receipt or expenditure takes place, all sales and purchases of goods by the Company and the assets and liabilities of the Company. Proper books shall not be deemed to be kept if there are not kept such books of account as are necessary to give a true and fair view of the state of the Company’s affairs and to explain its transactions.

171.

The books of account shall be kept at the Registered Office or at such other place as the Board of Directors thinks fit, and shall always be open to inspection by the Directors.

172.

The Board of Directors shall from time to time determine whether and to what extent and at what time and places and under what conditions or articles the accounts and books of the Company or any of them shall be open to the inspection of Members not being Directors, and no Member (not being a Director) shall have any right of inspection of any account or book or document of the Company except as conferred by law or authorised by the Board of Directors or by resolution of the Members.

AUDIT

173.

The accounts relating to the Company’s affairs shall be audited in such manner as may be determined from time to time by Ordinary Resolution of the Members or, in the absence of any such determination, by the Board of Directors or, in the absence of any determination as aforesaid, shall not be audited.

174.

The Board of Directors may appoint an auditor of the Company who shall serve as Auditor of the Company. The Auditor may be removed by a resolution of the Board of Directors and the Board of Directors may fix the Auditor’s remuneration.

NOTICES

175.

Except as otherwise provided in these Articles and subject to the Designated Stock Exchange Rules, at the discretion of the Board, any notice or document may be served by the Company to any Member either personally, or by posting it by airmail or by courier service in a prepaid letter addressed to such Member at his or her address as appearing in the Register of Members, or by electronic mail to any electronic mail address such Member may have specified in writing for the purpose of such service of notices, or by facsimile to any facsimile number such Member may have specified in writing for the purpose of such service of notices, or by placing it on the Company’s Website should the Board of Directors deem it appropriate. In the case of joint holders of a Share, all notices shall be given to that one of the joint holders whose name stands first in the Register of Members in respect of the joint holding, and notice so given shall be sufficient notice to all the joint holders.

176.

Any notice or document, if served by:

(a)

shall be deemed to have been served five (5) days after the time when the letter containing the same is posted;

(b)

facsimile, shall be deemed to have been served upon production by the transmitting facsimile machine of a report confirming transmission of the facsimile in full to the facsimile number of the recipient;

(c)

courier service, shall be deemed to have been served three (3) days after the time when the letter containing the same is delivered to the courier service;

(d)

electronic mail, shall be deemed to have been served immediately upon the time of the transmission by electronic mail; or

(e)

placing it on the Company’s Website, shall be deemed to have been served immediately upon the time when the same is placed on the Company’s Website.

177.

In proving service by post or courier service it shall be sufficient to prove that the letter containing the notice or documents was properly addressed and duly posted or delivered to the courier service.

178.

In the case of joint holders of a Share, all notices shall be given to that one of the joint holders whose name stands first in the Register of Members in respect of the joint holding, and notice so given shall be sufficient notice to all the joint holders.

179.

Any Member present, either personally or by proxy, at any meeting of the Company shall for all purposes be deemed to have received due notice of such meeting and, where requisite, of the purposes for which such meeting was convened.

180.

Any summons, notice, order or other document required to be sent to or served upon the Company, or upon any officer of the Company may be sent or served by leaving the same or sending it through the post in a prepaid letter envelope or wrapper, addressed to the Company or to such officer at the Registered Office.

181.

Any notice or document delivered or sent by post to or left at the registered address of any Member in pursuance of these Articles shall notwithstanding that such Member be then dead, insane, bankrupt or dissolved, and whether or not the Company has notice of such death, insanity, bankruptcy or dissolution, be deemed to have been duly served in respect of any Share registered in the name of such Member as sole or joint holder, unless the Member’s name shall at the time of the service of the notice or document, have been removed from the Register of Members as the holder of the Share, and such service shall for all purposes be deemed a sufficient service of such notice or document on all persons interested (whether jointly with or as claiming through or under such Member) in the Share.

WINDING UP

182.

The Board of Directors may present a winding up petition on behalf of the Company without the sanction of a resolution of the Members passed at a general meeting.

183.

If the Company shall be wound up, the liquidator shall apply the assets of the Company in satisfaction of creditors’ claims in such manner and order as such liquidator thinks fit.

184.

Subject to Article 25 and the special rights and restrictions attaching to Shares of any Class, if the Company shall be wound up, and the assets available for distribution amongst the Members shall be insufficient to repay the whole of the share capital, such assets shall be distributed so that, as nearly as may be, the losses shall be borne by the Members in proportion to the par value of the Shares held by them. Subject to Article 25 and the special rights and restrictions attaching to Shares of any Class, if in a winding up the assets available for distribution amongst the Members shall be more than sufficient to repay the whole of the share capital at the commencement of the winding up, the surplus shall be distributed amongst the Members in proportion to the par value of the Shares held by them at the commencement of the winding up subject to a deduction from those Shares in respect of which there are monies due of all monies payable to the Company for unpaid calls or otherwise. This Article is without prejudice to the rights of the holders of Shares issued upon special terms and conditions.

185.

Subject to Article 25 and the special rights and restrictions attaching to Shares of any Class:

(a)

if the Company shall be wound up (whether the liquidation is voluntary, under supervision or by the Court) the liquidator may, with the authority of a Special Resolution, divide among the Members in specie the whole or any part of the assets of the Company, and whether or not the assets shall consist of property of a single kind, and may for such purposes set such value as the liquidator deems fair upon any one or more class or classes of property, and may determine how such division shall be carried out as between the Members; and

(b)

the liquidator may, with the like authority, vest any part of the assets in trustees upon such trusts for the benefit of Members as the liquidator shall think fit, and the liquidation of the Company may be closed and the Company dissolved, but so that no Member shall be compelled to accept any Shares in respect of which there is liability.

INDEMNITY

186.

Every Director or officer of the Company shall be indemnified out of the assets of the Company against any liability incurred by that Director or officer as a result of any act or failure to act in carrying out their functions other than such liability (if any) that the Director or officer may incur by their own actual fraud or wilful default. No such Director or officer shall be liable to the Company for any loss or damage in carrying out their functions unless that liability arises through the actual fraud or wilful default of such Director or officer. References in this Article to actual fraud or wilful default mean a finding to such effect by a competent court in relation to the conduct of the relevant party.

187.

Expenses, including legal fees, incurred by a Director or officer of the Company, or former Director or officer of the Company, in defending any legal, administrative or investigative proceedings may be paid by the Company in advance of the final disposition of such proceedings upon receipt of an undertaking by such party to repay the amount if it shall ultimately be determined that such person is not entitled to be indemnified by the Company and upon such terms and conditions, if any, as the Company deems appropriate.

188.

The Board of Directors shall have the power to cause the Company to purchase and maintain insurance for the benefit of any person who is or was a Director or officer of the Company indemnifying them against any liability which may lawfully be insured against by the Company.

DISCLOSURE

189.

Any Director, officer or authorised agent of the Company shall, if lawfully required to do so under the laws of any jurisdiction to which the Company is subject or in compliance with the Designated Stock Exchange Rules upon which the Company’s shares are listed or in accordance with any contract entered into by the Company, be entitled to release or disclose any information in their possession regarding the affairs of the Company including any information contained in the Register of Members.

190.

Subject to the relevant laws, rules and regulations applicable to the Company, no Member shall be entitled to require discovery of any information in respect of any detail of the Company’s trading or any information which is or may be in the nature of a trade secret or secret process which may relate to the conduct of the business of the Company and which in the opinion of the Board of Directors would not be in the interests of the Members of the Company to communicate to the public.

191.

Subject to due compliance with the relevant laws, rules and regulations applicable to the Company, the Board of Directors shall be entitled to release or disclose any information in its possession, custody or control regarding the Company or its affairs to any of its Members, including information contained in the Register of Members and transfer books of the Company.

FINANCIAL YEAR

192.

The Board of Directors shall determine the financial year of the Company and may change the same from time to time. Unless they determine otherwise, the financial year of the Company shall end on 31 December in each year and shall begin on 1 January in each year.

AMENDMENTS TO MEMORANDUM AND ARTICLES OF ASSOCIATION

193.

The Company may from time to time alter or add to these Articles or alter or add to the Memorandum with respect to any objects, powers or other matters specified therein by passing a Special Resolution in the manner prescribed by the Companies Act.

TRANSFER BY WAY OF CONTINUATION

194.

The Company may by Special Resolution resolve to be registered by way of continuation in a jurisdiction outside the Cayman Islands or such other jurisdiction in which it is for the time being incorporated, registered or existing. The Board of Directors may cause an application to be made to the Registrar of Companies to deregister the Company in the Cayman Islands or such other jurisdiction in which it is for the time being incorporated, registered or existing and may cause all such further steps as they consider appropriate to be taken to effect the transfer by way of continuation of the Company.

CAYMAN ISLANDS DATA PROTECTION

195.

The Company is a “data controller” for the purposes of the Data Protection Act (as amended) (the “DPA”). By virtue of subscribing for and holding Shares in the Company, Members provide the Company with certain information (“Personal Data”) that constitutes “personal data” under the DPA. Personal Data includes the following information relating to a Member and/or any natural person(s) connected with a Member (such as a Member’s individual directors, members and/or beneficial owner(s)): name, residential address, email address, corporate contact information, other contact information, date of birth, place of birth, passport or other national identifier details, national insurance or social security number, tax identification, bank account details and information regarding assets, income, employment and source of funds.

196.

The Company processes such Personal Data for the purposes of:

(a)

performing contractual obligations (including under the Memorandum and these Articles);

(b)

complying with legal or regulatory obligations (including those relating to anti-money laundering and counter-terrorist financing, preventing and detecting fraud, sanctions, automatic exchange of tax information, requests from governmental, regulatory, tax and law enforcement authorities, beneficial ownership and the maintenance of statutory registers); and

(c)

the legitimate interests pursued by the Company or third parties to whom Personal Data may be transferred, including to manage and administer the Company, to send updates, information and notices to Members or otherwise correspond with Members regarding the Company, to seek professional advice (including legal advice), to meet accounting, tax reporting and audit obligations, to manage risk and operations and to maintain internal records.

197.

The Company transfers Personal Data to certain third parties who process the Personal Data on the Company’s behalf, including third party service providers that it appoints or engages to assist with its management, operation, administration and legal, governance and regulatory compliance. In certain circumstances, the Company may be required by law or regulation to transfer Personal Data and other information with respect to one or more Members to a governmental, regulatory, tax or law enforcement authority. That authority may, in turn, exchange this information with another governmental, regulatory, tax or law enforcement authority established in or outside the Cayman Islands.

EXCLUSIVE JURISDICTION AND FORUM

198.

Unless the Company consents in writing to the selection of an alternative forum, the courts of the Cayman Islands shall have exclusive jurisdiction over any claim or dispute arising out of or in connection with the Memorandum, these Articles or otherwise related in any way to each Member’s shareholding in the Company (a “Claim”), including but not limited to:

(a)

any derivative action or proceeding brought on behalf of the Company;

(b)

any action asserting a claim of breach of any fiduciary or other duty owed by any current or former Director, officer or other employee of the Company to the Company or the Members;

(c)

any action asserting a claim arising pursuant to any provision of the Companies Act, the Memorandum or these Articles; or

(d)

any action asserting a claim against the Company governed by the “internal affairs doctrine” (as such concept is recognised under the laws of the United States of America).

199.

Each Member irrevocably submits to the exclusive jurisdiction of the courts of the Cayman Islands over all such Claims and, for such purposes, each Member irrevocably waives (i) any objection to any proceedings in the courts of the Cayman Islands relating to such Claims on the ground of venue or forum non-conveniens and (ii) any right it has, or may in the future have, to bring proceedings relating to such Claims in any other courts.

200.

To the fullest extent permitted by law, the Company shall not be liable to any Member for or any indirect, special or consequential loss or damage, loss of profit, loss of business, loss of goodwill or anticipated savings arising out of or in connection with the Memorandum, these Articles or otherwise related in any way to each Member’s shareholding in the Company.

201.

Without prejudice to any other rights or remedies that the Company may have, each Member acknowledges that damages alone would not be an adequate remedy for any breach of the selection of the courts of the Cayman Islands as exclusive forum and that accordingly the Company shall be entitled, without proof of special damages, to seek the remedies of injunction, specific performance or other equitable relief for any threatened or actual breach of the selection of the courts of the Cayman Islands as exclusive forum.

Source: View Original Filing on SEC EDGAR

FAQ

What is Anbio Biotechnology (NNNN) asking shareholders to approve at the 2026 EGM?

Anbio Biotechnology seeks approval for a share capital reduction, a massive authorised share capital increase with new Class C and preference shares, higher Class B voting rights, Class B conversion into Class A, share consolidation authority, and adoption of updated memorandum and articles of association.

How will Anbio Biotechnology’s Class B voting rights change if Proposal Three passes?

If approved, each Class B Ordinary Share will carry 500 votes instead of 50. At the April 22, 2026 record date, this would cut Class A holders’ combined voting power from about 0.9% to roughly 0.1%, while Class B holders would control approximately 99.9% of voting power.

How many shares of each class could Anbio Biotechnology authorise under Proposal Two?

After the par value reduction, authorised capital would rise to US$3,000 divided into 3,000,000,000,000 shares of par value US$0.000001. This includes 800,000,000,000 Class A, 200,000,000,000 Class B, 1,000,000,000,000 non‑voting Class C, and 1,000,000,000,000 preference shares.

What are the current outstanding Anbio Biotechnology shares and voting power by class?

As of April 22, 2026, there were 43,891,200 Class A Ordinary Shares and 100,000,000 Class B Ordinary Shares outstanding. Each Class A carries one vote and each Class B fifty votes, giving Class A about 0.9% and Class B about 99.1% of total voting power before any changes.

What governance changes are included in Anbio Biotechnology’s Restated M&A?

The Restated M&A would reflect the capital and voting changes, raise the threshold to requisition a meeting to holders of a majority of voting rights, add an exclusive forum and jurisdiction clause, require prior written notice for director resignations, and make various consequential updates.

Filing Exhibits & Attachments

4 documents

Anbio Biotechnology (NNNN) seeks huge capital increase and 500-vote Class B shares

Rhea-AI Filing Summary

Positive

Negative

Insights

Equity & Governance Analyst neutral

Key Figures

Key Terms

FAQ

What is Anbio Biotechnology (NNNN) asking shareholders to approve at the 2026 EGM?

How will Anbio Biotechnology’s Class B voting rights change if Proposal Three passes?

How many shares of each class could Anbio Biotechnology authorise under Proposal Two?

Why is Anbio Biotechnology seeking share consolidation authority for its Class A Ordinary Shares?

What are the current outstanding Anbio Biotechnology shares and voting power by class?

What governance changes are included in Anbio Biotechnology’s Restated M&A?

Filing Exhibits & Attachments

Press Releases